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ABSTRACT 
Huntington’s disease is a neurodegenerative disease which presents with cognitive, 
motor and emotional-behavioural changes. Neural degeneration begins up to 20 
years prior to symptom onset, arising initially in the striatum. Motor symptoms are a 
hallmark; disturbances occur due to disruption of crucial motor pathways through 
atrophy. However, these are not seen until much later in the disease. Such findings 
raise questions about the role internal processes play in maintenance of function, but 
little is known about functional motor connectivity during early stages. 
Electroencephalography is a sensitive measure of the integrity of neural 
process occurring prior to, and at, motor execution. This thesis explores the 
relationship between electrophysiological premotor/motor activation and structural 
integrity of critical neuroanatomy providing intra-hemispheric and inter-hemispheric 
connectivity – the striatum and corpus callosum. In the principal study, 
presymptomatic persons showed abnormal premotor activation (Contingent Negative 
Variation); greater relative activation across the premotor period, accompanied by 
normal motor potentials (Readiness Potential) and execution (response time). 
Aberrant premotor activation likely reflects disruption of critical inter-hemispheric 
circuitry such as fronto-striatal networks and the corpus callosum. Results implicated 
compensation in a context of early atrophy and/or an inability to regulate responses. 
Extending this hypothesis, Study Two examines the relationship between 
premotor electrophysiological activity and morphology of the striatum using 
magnetic resonance imaging. Structural integrity of the caudate and putamen was 
theorised to determine the fronto-striatal neuroanatomical circuits subserving 
electrophysiological responses. Quantification of volume/shape yielded structure and 
function associations in our combined sample: timing (latency) and consistency 
(relative activation/slope) of the premotor response was determined by degeneration, 
  
xiii 
with greater atrophy predicting later and less consistent activation. This suggests 
compromise to motor pathways is progressive, and may first emerge as delayed, 
inefficient, and inconsistent electrophysiology. 
In Study Three, investigation was extended to the corpus callosum, which 
provides inter-hemispheric connectivity between primary and supplementary motor 
regions distinct from fronto-striatal pathways. It was proposed that atrophy to the 
corpus callosum (thinning) would disrupt both homotopic (e.g. parietal to frontal 
lobe) and heterotopic (e.g. left and right frontal lobe) circuits supporting 
premotor/motor connectivity. Raw correlations suggested compromise to mid-
posterior (motor) and mid-anterior (frontal cortex/premotor/supplementary motor) 
affects premotor performance (extent and consistency of response). While results did 
not survive stringent FDR error corrections, they followed known anatomical 
relationships, suggesting functional motor connectivity and premotor processing are 
also determined by structural integrity of the corpus callosum. 
These findings are important in showing early, disease-related morphological 
changes to the striatum and corpus callosum do disrupt critical fronto-striatal and 
inter-hemispheric networks.  Morphological changes accompanied by abnormal 
electrophysiological premotor activation support hypotheses of dysfunctional 
connectivity arising from atrophy to anatomical landmarks. Progression of circuit 
derangement may be mediated by secondary activation (e.g. supplementary motor 
areas, executive circuits) and typically indirect subcortical structures, which preserve 
function as connectivity with the primary motor area declines. Future studies using 
technology such as transcranial magnetic stimulation and diffusion tensor imaging 
may allow identification and stimulation of vulnerable and robust circuits 
respectively, potential intervention targets to preserve function and quality of life for 
longer.  
  
 
 
CHAPTER 1 – INTRODUCTION 
Clinical aspects of the disease, motor functionality and rationale for 
the investigation
1.1 Why Study Huntington’s Disease (HD)? 
 
- 1 - 
INTRODUCTION 
1.1 Why Study Huntington’s Disease (HD)? 
Huntington’s disease (HD) is an inherited disease which causes irreversible damage to the 
brain, significantly impairing a person’s ability to move, think, express emotions, and socially 
interact. The disease is progressive; symptoms begin to appear at around age 40, with death 
occurring 10-15 years later.  HD is a hereditary disease, caused by a mutation to a single gene 
Huntingtin (HTT), found on the short arm of chromosome 4 (4p16.3). The HTT gene causes 
an excessive production of a triplet chain of nucleotides (building blocks of DNA) to occur 
within the Huntingtin protein (htt). This chain is called the cytosine-adenine-guanine (CAG) 
repeat, named after the particular nucleotides involved. In HD, an abnormal expansion of 
CAG creates excessive polyglutamine sequences within the htt protein (Landles & Bates, 
2004). These sequences cause the protein to become unstable and result in characteristic, 
toxic patterns of aggregation over time (Ramaswamy, Shannon & Kordower, 2007). Though 
its broad range of functions within neurons is complex and are not completely known, normal 
htt plays a role in the natural death of cells within the body. When an individual has over 36-
39 CAG repeats the htt protein becomes abnormal, unstable and toxic, leading to neuronal 
cell death, and neurodegeneration in critical areas of the brain involved in connectivity of 
motor, cognitive and emotion circuits. Detection of a significant number of repeats through 
genetic testing has enabled identification of individuals who will go on to develop the 
disease; however, the disease remains incurable.  
HD is typically considered as having three main sequential stages. There is the early, dormant 
phase of the disease, where the individual does not experience any symptoms (non-manifest, 
stage 1). This is followed by the slow emergence of signs and symptoms of HD, which may 
or may not be noticeable to the individual (referred to as the presymptomatic or prodromal 
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stage; pre-HD, stage 2). Both stage 1 and 2 occur approximately between birth and age 40. 
The final stage is termed the symptomatic stage (symp-HD, stage 3), where the individual 
displays characteristic signs and symptoms of HD, which occur as the particular patterns of 
damage to the brain affect circuitry which controls movement, mood, and other functions. 
Motor symptoms involve impairment to existing movements, as well as the addition of 
involuntary movements. For example, individuals may have changes to gait (walking) but 
could also develop shaking, dance-like movements (termed chorea). Mood disturbances can 
occur, including increased aggression, personality changes, depression, and psychotic 
features (Walker, 2007). In HD, symptoms develop over a course of 15-20 years, with 
individuals progressively losing their ability to walk, talk, and feed themselves. Death occurs 
from secondary complications of the disease, including falls, infection, or choking (aspiration 
pneumonia; Nance, Paulsen, Rosenblatt, & Wheelock, 2011). There are no known 
preventative treatments for HD. Currently, some medications are used to treat particular 
symptoms (i.e. symptomatic treatments), such as psychotic episodes and tremor, and non-
pharmacological interventions such as physiotherapy and psychotherapy are used to manage 
physical and psychological deterioration. However, current treatments are unable to modify 
or slow the progression of the disease. 
While symptomatic onset typically begins at age 40 (The Huntington’s Disease Collaborative 
Research Group, 1993), longitudinal research has identified functional changes in areas of 
cognition, behaviour, memory and movements that precede formal diagnosis by up to 20 
years (Duff, Paulsen, Beglinger, Langbehn & Stout, 2007; Feigin, Ghilardi, & Huang, 2006; 
Kipps et al., 2005; Nopoulos et al., 2007; Paulsen, Hayden & Stout, 2006; Paulsen, Langbehn 
& Stout, 2008; Paulsen, Magnotta, & Mikos, 2006; Reynolds, Prost, & Mark, 2005; 
Solomon, Stout & Johnson, 2007), suggesting that impairment occurs progressively 
throughout the entire course of the disease. Supporting evidence from structural imaging 
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suggests that pathophysiological changes in HD begin years prior to formal diagnosis 
(Aylward et al., 2012; Domínguez et al., 2013; Georgiou-Karistanis et al., 2013a; Paulsen, 
2010; Tabrizi et al., 2009; Tabrizi et al., 2011; Tabrizi et al., 2013; van den Boggard et al., 
2011a, b). Abnormal htt causes premature death of brain tissue (neurons) both globally and 
within specific structures such as the striatum. This part of the brain is involved in the 
regulation of cognitive, emotional, behavioural, and motor functions. Previous studies have 
hypothesised that through early changes to the striatum, brain circuitry (fronto-striatal 
pathways) may be disrupted, which should, theoretically, result in cognitive, motor and 
emotional impairment. Again arising from neurodegeneration, global brain atrophy also 
occurs in HD, and may affect frontal and premotor-motor cortical regions, which may be 
reflected in structural changes in the major inter-hemispheric neuronal white matter 
connection, the corpus callosum. Thus, in parallel with brain imaging studies, there has been 
a focus on identifying changes in cognitive, emotion and motor functions that could be 
clinical markers of disease progression related to neurodegenerative structural changes, such 
as in the striatum and corpus callosum. Ideally, such changes could be frequently assessed 
clinically in a cost-effective manner and in a wide range of settings.  
One such avenue to investigate functional changes in HD involves motor tasks. HD is 
predominantly considered a movement disorder, and affects key regions in connectivity of 
indirect and direct motor pathways (the striatum and corpus callosum). However, despite 
characteristic neurodegeneration, those in early stages of HD present with minimal functional 
motor differences in comparison to healthy persons. While some studies have identified 
subtle changes in motor execution in early stages (such as intervals between finger taps), 
these have been in larger samples, and have not been replicated. A major limitation of such 
findings is that they relate to a single task, and are likely to lack sensitivity as the disease 
progresses. Additionally, little is known about functional impairment in early stages; if 
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neurodegeneration of the striatum and crucial circuitry (fronto-striatal circuits and the corpus 
callosum) is compromised 20 years prior to symptom onset, how does such damage 
functionally manifest in terms of motor function? It is critical to identify other functional 
motor tasks that may quantify cerebral changes in the prodromal (pre-HD) period and aid in 
understanding of neuropathology.  
Electroencephalography (EEG) may provide a window into functional motor changes in HD. 
Use of EEG technology could allow detection of sub-clinical differences in brain function 
and subtle changes in neural processes, resulting from such atrophic disruption of motor 
pathways. EEG is advantageous over traditional motor tasks which are limited in sensitivity 
and temporal resolution. Specifically, EEG enables investigation of changes in the early 
stages of motor planning, before any movement is enacted. These specific motor changes 
could represent potential endophenotypic features of HD, and, when combined with structural 
imaging, may inform us about the structural-functional integrity of specific neural circuitry 
involved in the pathophysiology of HD. Thus, while premotor neural activity may be 
implicated by EEG studies, the combination of EEG with imaging would provide a better 
understanding of the particular neural circuits which are impaired during early stages of the 
disease, and how these relate to functional performance. Amalgamation of function and 
structure is particularly relevant to HD where no method is currently available to track 
disease progression prior to the appearance of cognitive, emotional and motor symptoms, and 
where pathology is still poorly understood. In this thesis, I aim to investigate the relationship 
between relevant brain structures implicated in HD neurodegeneration and motor 
performance, by combining electrophysiological measures of premotor and motor activation 
with morphological features (volume and shape) of critical regions involved in motor 
connectivity (the striatum and corpus callosum). 
1.2 Structure of the Thesis 
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1.2 Structure of the Thesis 
This thesis comprises three thematically related research studies, presented as two published 
papers, with a third under review. A schematic diagram demonstrating the relationship 
between these studies is presented in Figure 1.1, and will be referred to throughout the thesis. 
In doing so, I provide a context for each study in terms of the body of work as a whole.  
 
Figure 1.1 Schematic diagram illustrating overall thesis structure. 
 
HD: Huntington’s disease 
Electrophysiological measures of motor function - RP: Readiness Potential, CNV: Contingent Negative 
Variation 
 
The studies in this thesis seek to explore the structural (neural circuit component integrity) 
and functional (electrophysiological) bases of the known relative preservation of motor 
functionality in pre-HD and early HD. The introduction begins with general literature on HD,
1.3 General Introduction 
 
- 6 - 
exploring epidemiology, clinical motor impairment, and genetic factors. This is followed by a 
discussion of structural changes to the brain and neuropathology, including review of 
neuroanatomical and functional connectivity literature and the range of neuropathology 
insults to motor circuitry. This highlights the poor understanding of the relative preservation 
of motor functioning in early stages of HD and provides a rationale for structure-function 
investigations. I then discuss existing motor tasks and electrophysiological studies, providing 
a background for Study One, which explores the Readiness Potential (RP) and Contingent 
Negative Variation (CNV) as more sensitive measures of electrophysiological premotor and 
motor function than traditional motor tasks. This leads into the Second and Third studies, 
which examine intra- (fronto-striatal) and inter-hemispheric (corpus callosum) connectivity 
and relationship to motor function. The introduction is concluded by an outline of study aims 
and hypotheses 
 
1.3 General Introduction 
1.3.1 Epidemiology  
HD is a relatively rare disease, affecting approximately 5-7 people per 100,000 worldwide 
(Bates, Tabrizi & Jones, 2014). Specific incidence rates range from approximately 0.5 to 7.8 
per 100,000, varying geographically due to factors of population density, ancestry, ethnicity 
and migration history (Walker, 2007). Prevalence is greatest in Western countries, including 
the United States, Canada, Australia and South Africa, and in Caucasian individuals of 
Western European origin (Vonsattel, DiFiglia, 1998). CAG repeats have been found to be 
similar across cultures (Kremer et al., 1994), including within concentrated populations, such 
as regions of Venezuela, Tasmania, Scotland, Sweeden and Wales (Harper, 2002; Pridemore, 
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1990). In Australia, HD is estimated to affect 6.29 people per 100,000 (McCusker, Casee, 
Graham, Williams, & Lazarus, 1996).  
Estimates of prevalence have improved with identification of HTT, which, along with post 
mortem examination, allows confirmation of suspected HD cases in deceased individuals. 
Suspected clinical cases are diagnosed by symptomatic onset, using assessment tools such as 
the Unified Huntington’s Disease Rating Scale (UHDRS), which assess the severity of 
involuntary movements, impairment of purposeful movements, and presence of abnormal 
motor signs, along with associated cognitive and functional changes (Huntington Study 
Group, 1996). However, these measures require clinical judgment, and are completely 
dependent upon dysfunction being overt. In reality, motor dysfunction may begin years prior 
to manifest signs of disease, accompanying atrophy, and sub-clinical onset could represent an 
ideal point of intervention in the disease process if detectable by more sensitive functional 
motor measurements.  
 
1.3.2 Clinical Motor Symptoms/Signs 
Motor symptoms (subjective impairment) and signs (observable impairments) have long been 
considered the hallmark of HD; approximately 90% of cases of adult onset HD involve 
chorea, or involuntary dance-like movements (Nance et al., 2011). There is a trajectory of 
gradual impairment (Nance et al., 2011). However, individual variation due to factors such as 
age (Foroud, Gray, Ivashina, & Conneally, 1999), environment (Van Dellen, Cordery, Spires, 
Blakemore & Hannan, 2008; Wexler et al., 2004), genetics (Marder, Sandler, Lechich, 
Klager, & Albert, 2002), and previous mobility, has been noted. Table 1.1 provides an 
overview of early, intermediate and late clinical motor signs in HD. 
 
1.3 General Introduction 
 
- 8 - 
Table 1.1 Clinical motor signs and symptoms in HD by stage. 
Information modified from Nance et al. (2011). 
Involuntary movements (chorea), motor slowing (bradykinesia), and unsteadiness (ataxia) 
initially involve the extremities as well as the neck, trunk and shoulders. As the disease 
progresses, symptoms go on to affect facial muscles, and facial motor dysfunction can impact 
on speech and swallowing (Hamilton et al., 2012). Difficulty initiating saccadic eye 
movements is one of the earliest signs of motor impairment in HD (Nance et al., 2011). 
Motor slowing may become evident in absence of facial expressions, and arm and hand 
movements (Nance et al., 2011). Difficulties emerge in alternating movements (switching), 
finger tapping, and initiating and maintaining constant gait (Delval et al., 2004; Nance et al., 
2011). Muscle rigidity is a severe symptom seen in late stages; tonal changes reduce the 
range of motion, and create resistance in both voluntary and passive postures and movements 
(Bates et al., 2014). Impaired fine movements and praxis further diminish the person’s 
capacity for self-care and independent living, which often necessitates hospitalisation or 
nursing home care (Nance & Sanders, 1996).   
In addition to the above, more subtle dysfunction emerges in inconsistent motor persistence 
(maintenance of muscle contractions; Gordon, Quinn, Reilmann, & Marder, 2000), delayed 
movements (Jahanshahi, Brown, & Marsden, 1993), and execution and maintenance of 
Early Intermediate Late 
Impaired saccadic eye 
movements 
Muscle stiffness and general 
motor slowing 
Muscle rigidity 
Greater variability in motor 
precision (e.g. finger tapping) 
Chorea Restricted range of motion 
 
Difficulty swallowing and 
impaired speech 
Inability to attend to activities 
of daily living  
 
Problems initiating and 
maintaining gait 
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movement (Folstein, Jensen, Leigh, & Folstein, 1983). These difficulties are not necessarily 
identified by standard clinical scales such as the UHDRS, and suggest a progressive 
breakdown of motor efficiency begins prior to the observable dysfunction in symptomatic 
stages. Movement slowness increases with task complexity and the requirement for 
simultaneous movements (Currà et al., 2000; Thompson et al., 1988), however, can arise in 
part to enhance motor precision (Phillips et al., 1996), suggesting that individuals may 
compensate consciously (or unconsciously) for progressive motor impairment. The 
unequivocal presence of observable motor dysfunction is necessary for a clinical diagnosis of 
symp-HD (Beglinger et al, 2010). Thus, onset is dependent upon specific identification of 
clinical symptom and signs, which, rather than a discrete outcome, may represent a spectrum 
of impairment (Biglan, 2010). Earlier detection of motor abnormalities may assist in earlier 
diagnosis, representing an ideal point to trial interventions. The delayed nature of motor 
symptoms in HD, coupled with early neurodegeneration to regions of the brain responsible 
for motor control (i.e the striatum) and general connectivity (the corpus callosum), raises 
questions regarding precisely where, when and how motor dysfunction begins in the disease.  
 
1.3 3 Genetics and Molecular Neuropathology 
In 1993, the Huntington’s Disease Collaborative Research Group isolated the 4p16.3 
Huntingtin HTT gene, which occurs normally in the human genome, encoding for a normal 
Huntingtin htt protein. HD has an autosomal dominant mode of inheritance; a single copy of 
the gene containing the mutation in either parent is sufficient for inheritance (Gusella, 2007) 
and both males and females are equally afflicted (Jorde et al., 2006). A child with one parent 
with the gene has a 50% chance of inheriting the gene. Most instances of HD are 
heterozygous, with a single gene inherited from one parent (Kremer et al., 1994). In highly 
localised HD populations such as Lake Macaibo, homozygous or mutational inheritance from 
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both parents is seen. The disease course of the homozygous genotype is no more severe in 
nature than the heterozygous (Kremer et al., 1994), implying that regulation of htt may occur 
through other neural mechanisms, which could act as compensatory.  
Htt is a large protein (MacDonald, Gines, Gusella, & Wheeler, 2003), and is located 
primarily in the cytoplasm (Velier et al., 1998) with approximately 5% found in the nucleus 
(De Rooij et al., 1996). The htt protein’s amino terminal function is capable of binding 
numerous multifunctional proteins (Jones, 2000), suggesting it plays a significant role in the 
organisation and binding of other proteins (MacDonald et al., 2003). Although the exact role 
of htt is unknown, rodent models demonstrate its necessity for cell maintenance (Dragatsis et 
al., 2000), as well as development of the embryo and central nervous system (Duyao et al., 
1995; White et al., 1997; Zeitlin et al., 1995). When the polyglutamine tract is expanded, the 
mobility of the protein is slowed (Gutekunst et al., 1995) altering the structure and causing htt 
acetylation and related aggregation (Aiken et al., 2009; Jeong et al., 2009). These changes 
results in the selective and progressive toxicity of neuronal cells in the basal ganglia: 
primarily, the caudate nucleus, putamen, globus pallidus, and nucleus accumbens (Squitieri et 
al., 2005) through an unknown mechanism (Arrasate & Finkbeiner, 2012).  
The size of the expansion (number of CAG repeats) varies across individuals, and correlates 
with degree of neuropathology (Penney et al., 1997). Normal CAG expansions range from 10 
to 35 (Nance et al., 2011); however, repetitions greater than 28 become increasingly unstable 
(Walker, 2007). In HD, the mutant 4p16.3 HTT gene contains an abnormal expansion of a 
string of trinucleotides (CAG), greater than 40 in number, which encodes an extended 
polyglutamine tract in the resultant htt protein, rendering the protein unstable. Reduced 
penetrance in HD occurs in expansions ≥ 36; however isolated incidences of HD variants in 
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CAG expansions fewer than 36 have been recorded (Andrich et al., 2008; Kenney et al., 
2007). In HD, full penetrance occurs in repeats ≥ 41, while those with repeats of 36 to 41 
may not develop symptoms or these may occur very late in life (The American College of 
Medical Genetics, 1998; Brinkman, Mezei, Theilmann, Almqvist & Hayden, 1997), which 
may implicate a HD-like phenotype. Genetic ‘anticipation’ can cause trinucleotide mutations 
to change size over successive generations (Teisberg, 1995). This can entail CAG expansions 
to lengthen or contract; however, expansions are more common. As repeats increase, HD can 
affect descendants at subsequently younger ages and with greater severity than previous 
generations (Gusella & MacDonald, 1994; Nance & Meyers, 2001). In adults, expansion size 
is considered to hold an inverse and predictive relationship with age of onset (e.g. Duyao, 
Ambrose & Myers, 1993), explaining approximately 70% of the variance (Brinkman, et al., 
1997; Rosenblatt et al., 2011), however recent evidence suggests a much more indirect 
relationship with other genetic or epigenetic factors involved (Lee et al., 2012). However, a 
number of anomalies in reports suggest that individuals with an expansion of the same length 
can vary in onset by as much as 36 years (Gusella & MacDonald, 2002). The considerable 
individual variation in onset highlights the need to consider the disease dimensionally, rather 
than categorically, as well as the urgency to identify more robust and sensitive measures of 
disease progression.  
 
1.4 Disease-Related Structural Changes to the Brain 
1.4.1 Neuropathology and Neuroanatomy  
In HD, the abnormal htt protein is deposited in the brain forming aggregates both globally 
and in vulnerable structures such as the striatum (Landles & Bates, 2004). This creates a 
cascade of changes resulting in cell death (apoptosis). Cerebral atrophy occurs through a 
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combination of widespread neuronal loss, astrogliosis (a compensatory increase in glial cells 
in the brain due to local necrosis), and astrocytic proliferation (Vonsattel et al., 1985; 
Vonsattel, Keller, & Ramierez, 2011). In HD, gross brain atrophy occurs in the striatum, with 
significant reduction of brain volume seen in the caudate (Aylward et al., 1997; Paulsen et al., 
2008; Rosas et al., 2001) as well as cortical regions (Hedreen et al., 1991; Rosas et al., 2002; 
Vonsattel et al., 1985).  In pre-HD, one MRI study suggests that over 50% of cell death has 
occurred in the striatum by the time formal diagnosis of HD occurs (Aylward, Sparks & 
Field, 2004); effect size comparisons suggest that the regions of the striatum exhibit the most 
prominent difference from controls than any other brain region (Nopoulos, Johnson, 
Magnotta, 2009). 
Morphological changes in HD provide a clear diagnostic marker in neuroimaging and post 
mortem examination. At death, approximately 18 years after symptom onset, overall brain 
weight is reduced by one third (Vonsattel & DiFiglia, 1998). As volume decreases, 
hydrocephalus occurs and cerebrospinal fluid (CSF) takes over atrophied areas (Jayaraman, 
Garofolo, & Donnenfeld, 1978; Tang, Lieberman, & Rovit, 1975). Neuroimaging studies 
using MRI have demonstrated changes in brain structure and function begin to occur in HD 
up to 20 years prior to symptom onset (Aylward et al., 2012; Domínguez et al., 2013; 
Georgiou-Karistanis et al., 2013a; Tabrizi et al., 2009; Tabrizi et al., 2011; Tabrizi et al., 
2013; van den Bogaard et al., 2011a,b). Beginning in the pre-HD stage, atrophy to the 
striatum and corpus callosum (Henley et al., 2009; Squitieri et al., 2009; Rosas et al., 2002) 
are accompanied by cortical thinning (Rosas et al., 2005), with pronounced thinning in 
posterior regions of the brain (Tabrizi et al., 2009). Pathology extends to progressive grey and 
white matter loss and degeneration of the corpus callosum (Ciarmiello et al., 2006; Rosas et 
al., 2008; Ruocco et al., 2006; Thieben et al., 2002). Ventricular enlargement occurs up to 5 
years prior to motor symptom onset and appears to accelerate with disease duration (Squiteri 
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et al., 2009); however, natural brain variation occurs among individuals in preclinical 
volumes which can create variation in morphological changes (Hobbs et al., 2010). This 
makes detection of between group changes in structural measures alone difficult when 
tracking individual disease progression. In individuals 10 years from onset, an estimated 3-
8% volume loss occurs globally, compared with age-matched controls (Paulsen et al., 2006; 
Tabrizi et al., 2009). Comparatively, voxel-based morphometry and volumetric measures 
identify volume changes to the caudate and putamen 16 years prior to clinical onset (Aylward 
et al., 2004; Ciarmiello et al., 2006; Paulsen et al., 2006; Tabrizi et al., 2009).   
 
1.4.2 Implications for Motor Connectivity 
Beginning in early stages of the disease, atrophy creates abnormal inter-hemispheric 
interactions; functional brain imaging studies show pre-HD individuals demonstrate reduced 
neural activation in fMRI (Zimbelman et al., 2007) and reduced racloprodide (D2 dopamine 
receptor) binding (Weeks, Pinccini, Harding, & Brooks, 1996). These changes, accompanied 
by white matter loss (Ciarmiello et al., 2006; Tabrizi et al., 2009), support a reduction in 
functional connectivity beginning in premanifest stages (Wolf et al., 2007) which may have 
subtle consequences for motor function.  
Functional motor connectivity is dependent on structural integrity of core grey matter (within 
hemisphere) inteneuronal relay regions (caudate and putamen), as well as structures which 
traverse the right and left hemispheres of the brain (commissures) such as the corpus 
callosum (Draganski et al., 2008). In pre-HD, weakened connectivity of the primary motor 
area (M1) with the sensorimotor and supplementary motor areas (Koenig et al., 2014), and 
premotor areas of the caudate (Unshuld et al., 2012b) have been identified. There is 
suggestion that M1 connectivity itself may be dependent upon structural integrity of 
supporting regions; larger bilateral putamen and globus pallidus volumes are associated with 
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improved connectivity with the right precentral gyrus, and the right and left cuneus (Koenig 
et al., 2014).  
If changes in functional connectivity commences early in the disease, this raises the question 
of why do persons with pre-HD generally present without functional impairment? There are 
two main possibilities, which may be equally accurate. First, there is a possibility that 
atrophic disruption of functional connectivity does cause motor changes in pre-HD, but that 
these changes are too subtle to be detected by current tasks. For example, in symp-HD 
intrinsic connectivity disturbances have been accompanied by increased connectivity 
throughout the sensorimotor network (Werner et al., 2014), while connectivity changes in 
pre-HD are not typically as widespread, and may not be as overt. This leads into the second 
possibility: connectivity changes do not cause general motor impairment due to a process of 
compensation through other neural networks. This may occur through hyperactivation of 
existing circuitry, and/or recruitment of additional circuits through network despecialisation.  
For example, Wolf et al (2012) found reduced connectivity between M1 and the 
supplementary motor area in pre-HD (the primary motor circuit), but only in individuals far 
from disease onset, i.e. with the required number of CAG repeats to develop disease, but 
predicted to have later onset than other participants. This may suggest that an early 
breakdown in connectivity of M1 is able to be compensated for prior to a significant degree 
of neurodegeneration, and highlights that examination of brain structure alone in the disease 
may shroud significant changes to neural networks and connectivity. Alternatively, individual 
hyperactivation itself may be overlooked as a stage in progressive breakdown of circuit 
connectivity. In pre-HD, one study has shown increased motor dysfunction accompanies 
reduced synchronisation between the ipsilateral ventral and somatosensory cortices (Koenig 
et al., 2014), creating unregulated, unmediated activation of cortices, while other studies 
show either abnormal, reduced M1 synchronisation with sensorimotor cortex (Poudel et al., 
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2014a), or normal sensorimotor network connectivity (Dumas et al., 2013). Hyper 
connectivity in pre-HD stages may represent an intermediate phenotype of cell dysfunction 
prior to frank cell death and appears to vary considerably across individuals (Tobin & Signer, 
2000). Indeed, it has been suggested that M1 neuronal connectivity within sensorimotor areas 
may depend on the number of CAG repeats, a measure of disease severity (Koenig et al., 
2014). In a degenerating brain, such enhanced connectivity could reflect an inability to 
regulate essential neural networks involved in motor control, which ultimately results in 
detriment to initiation, execution and efficiency of motor responses as networks fail.  
Difficulties regulating connectivity are likely to occur progressively in HD; however, these 
neural mechanisms are not well understood, nor the preservation of motor functioning in pre-
HD stages. If dysfunction of motor circuitry can be detected functionally and non-invasively, 
prior to the onset of clinical symptoms, this paired with structure, may represent a more 
comprehensive and viable measure of disease progression. One way this may be elucidated is 
by examining the relationship between structural integrity of crucial brain regions and 
functional motor connectivity, such as during a sensitive motor task. Through its sensitivity 
to subtle firing changes and its enhanced temporal resolution, EEG may enable the detection 
of dysfunction to motor circuitry in more subtle ways, such as over-activation and regulation 
of electrophysiological premotor and motor responses. From a neuroanatomical rationale, the 
striatum is a key region of interest: it is an early target in degenerative processes, and motor 
connections from key motor circuits (premotor, motor, dorsolateral prefrontal cortex) are 
localised to the key structures (the caudate head, body, and medial and lateral aspects of the 
putamen; Alexander et al., 1986; Draganski et al., 2008; Haber et al., 2000; Haber et al., 
2003). Based on this rationale, structural neurodegeneration should disrupt fronto-striatal 
networks involved in motor control, and may progressively undermine motor connectivity 
and functionality.
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1.5 Regions of Interest: The Striatum 
1.5.1 Functional Neuroanatomy of the Striatum 
The striatum is the primary structure compromised in HD and contains the caudate nucleus 
and putamen (Squitieri et al., 2005; Figure 1.2). A crucial hub in recurrent fronto-striatal 
neural circuits, the striatum receives indirect and direct motor connections from the motor, 
supplementary, and premotor cortices, cingulate motor area, and frontal eye fields (Jahanshai 
et al., 2015). Connections to subcortical structures, such as the superior colliculus, pontine 
nuclei, pendunculopontine nucleus, periaqueductal grey, and medullary reticular formation, 
aid indirectly in motor control (Erro et al., 1999; Krout & Loewy, 2000; Krout et al., 2001).  
 
 
Figure 1.2 Gross anatomy of the striatum. Gross anatomy of the striatum. Caudate (red), putamen (blue) are 
identified. The globus pallidus (green) is marked for reference. Modified from original images under Creative 
Commons (CC-BY) licensing. 
 
1.5 Regions of Interest: The Striatum 
 
- 17 - 
Functionally, regulation of the striatum is crucial for successful motor planning, execution, 
and inhibition, and requires activation of parallel and converging fronto-striatal circuits of the 
motor, premotor, and dorsolateral prefrontal cortex and subcortical structures (DLPFC; 
Abbruzzese & Berardelli, 2003; Alexander et al., 1986; Jahanshashi, 2015). Striatal 
connections are topographically organised; the caudate head and body receive connections on 
the lateral aspect from the DLPFC, inferior orbitofrontal cortex and posterior parietal cortex, 
and connections of the medial aspect from the anterior cingulate cortex. The tail of the 
caudate receives connection from the frontal eye fields, a lesser-known motor circuit 
regulating visual attention and eye movements. The putamen receives far more motor 
connections, with connections to the motor cortex and somatosensory cortex on its medial 
aspect, the supplementary motor area on its lateral aspect, and the DLPFC on its ventral 
aspect (Alexander et al., 1986; Draganski et al., 2008; Haber et al., 2000; Haber et al., 2003). 
These two structures are also internally linked through white matter fibres of the internal 
capsule. Thus the caudate and putamen are crucial components of parallel fronto-striatal 
circuits, due to their anatomical and functional links to the frontal cortex (Alexander et al., 
1986). Figure 1.3 presents the key inter-hemispheric parallel and converging motor circuits 
(including premotor, motor, and DLPFC) which project on to the caudate and putamen 
structures (Alexander et al., 1986; Cummings, 1993). 
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Figure 1.3. Striatal afferent connections: surface regions of the striatum which receive afferents from 
respective regions of cortex. Reproduced with permission from Looi et al. (2011).  
 
1.5.2 Neuropathology of the Striatum 
The striatum is a key anatomical marker in HD. Atrophy correlates with degree of 
neuropathological involvement in the disease (Vonsattel & DiFiglia, 1998). While the htt 
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protein is ubiquitously expressed in cells throughout the body, including those brain and 
peripheral organs (Davies & Ramsden, 2001), high concentration is found in the striatal 
neurons (Ferrante et al., 1987). Striatal neurons have difficulty compensating for mutated htt 
and have low resistance to degeneration, due to the predominance of medium spiny neurons 
(MSN; Ferrante et al., 1987). MSN are responsible for interneuronal transmission and release 
of GABA (Gamma aminobutyric acid; Landles & Bates, 2004), and loss of neurons results in 
net changes that lead to hyperactivation of the thalamus (loss of tonic inhibition) and resultant 
thalamo-cortical hyperexcitability (Han, Cortex & Snead, 2010; Ulrich, Besseyrias, & 
Bettler, 2007), changes which over time promote neural desynchrony and atrophy. Neuronal 
loss is far less pronounced across other subcortical and cortical structures, compared to the 
striatum (Myers et al., 1991). 
Loss of MSN produces a number of neuropathological changes in the striatum. Regional 
atrophy is accompanied by significant striatal reductions in cerebral blood flow (CBF; 
Hasselbalch et al., 1992; Sax et al., 1996; Tanahasi et al., 1985), which may trigger cortical 
atrophy through ischemic cascade (restriction of blood flow to tissue). One study found that 
significant reductions in CBF to the caudate and putamen exceeded volume loss in affected 
regions, and were paradoxically accompanied by CBF elevation in the globus pallidus, 
suggesting the process of degeneration is complex and compensation may occur (Chen, Salat, 
& Rosas, 2012). Decreased striatal CBF (striatal hypoperfusion) itself may represent neuronal 
dysfunction which occurs prior to atrophy (Nopoulos et al., 2010; Rosas et al., 2008). The 
striatum may be particularly vulnerable to CBF changes due to high metabolic demand and 
energy requirements in these regions (Browne et al., 1997). Resting cerebral metabolism 
studies identify abnormal metabolic processes in both striatal and extra-striatal areas 
(Bartensetein et al., 1997; Berent et al., 1988; Tanahasi et al., 1985); however, findings are 
divided on whether disease-related metabolic alterations are most profound in the putamen 
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(Herben-Dekker et al., 2014) or the caudate nucleus (Tabrizi et al., 2012). Both structural and 
metabolic changes represent neuronal and cellular dysfunction, which begins well before cell 
death. These processes highlight the complex and progressive nature of neurodegeneration in 
early stages of the disease, and the importance of understanding when and where functional 
changes may arise through atrophy.  
Striatal atrophy begins with MSN loss in the dorsal medial head of the caudate, with rostral 
progression to the ventrolateral striatum (Gutekunst et al., 1999; Vonsattel & DiFiglia, 1998). 
As the disease progresses the caudate nucleus flattens and becomes concave on its medial 
surface (Douaud et al., 2009).  Advanced atrophy of the caudate head creates the appearance 
of enlarged frontal horns of the lateral ventricles (Dormont & Seidenwurm, 2008; Paulsen et 
al., 2004). The caudate makes an excellent neuroimaging marking due to its clear anatomical 
boundaries (superior to that of the putamen), and is the main imaging marker used in 
confirming symptomatic status in individuals with suspected HD (see Figures 1.4 and 1.5). In 
suspected symp-HD, the distance between caudate heads increases through atrophy, creating 
a sharp contrast between the width of the inner table of the skull (Dormont & Seidenwurm, 
2008). Neuroanatomically, the caudate and putamen are excellent candidates to measure 
longitudinal degenerative progression; the caudate nucleus has been demonstrated to decline 
linearly in volume up to 20 years from predicted motor onset (Aylward et al., 2004). In a 
longitudinal study of genetically diagnosed individuals with HD using semi-automated 
segmentation of the striatum, caudate volumes began to deviate from normal and decline 
linearly approximately 14 years prior to date of motor onset, with low variability among 
individuals (Hobbs et al., 2010). However, heterogeneity across caudate volumes has been 
identified cross-sectionally in individuals with the same disease duration despite accounting 
for covariates (age, sex, index of head size, CAG size; Hobbs et al., 2010). In pre-HD 
caudate, atrophy rates are estimated to be around 1-4% per year (Aylward et al., 2003; 
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Aylward et al., 2011; Hobbs et al., 2009; Kipps et al., 2005; Tabrizi et al., 2011) with 
putaminal rates between 3-7% (Tabrizi et al., 2011).  
 
 
Figure 1.4 MRI comparison of normal and HD brain. A. Healthy control, B. symptomatic HD. Axial T1 and 
T2 weighted images; T1 highlights high fat tissue (white matter; bright on image) and CBF (dark) to 
demonstrate anatomy, and shows mild cortical and cerebral atrophy with enlargement of frontal horns; T2 is 
reverse contrast to demonstrate pathology (high fat tissue appears dark, CSF appears bright) and shows bilateral 
atrophy to the caudate head. Modified from original images under Creative Commons (CC-BY). 
T1 T2 
A. 
B. 
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Figure 1.5 Manual tracing of the caudate nucleus using ANALYZE 11.0 (Mayo Foundation, Rochester, MI, USA) software. Traces are shown in transverse, coronal, and 
sagittal slices. Traces yield a 3D binary shape for the structure for each individual, and enable calculation of volume for left, right and bilateral caudate and putamina.
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1.5.3 Striatal Connectivity 
Neural circuits enable communication between the left and right hemispheres of the brain. 
Effective inter-hemispheric communication depends on functional connectivity, and in the 
striatum connectivity also maintains afferent, intra-hemispheric, connections between 
specific regions of the caudate and putamen (Draganski et al., 2008). As atrophy progresses, 
connectivity to the striatum through such circuitry may become disrupted. Derangement of 
circuits contributes to cortical dysfunction, and loss of motor function; greater atrophy occurs 
through processes of hypoperfusion, where a loss of circulating fluid and tissue contributes to 
further necrosis. Atrophy to striatal regions (putamen, caudate and globus pallidus) has been 
associated with reduced M1 connectivity to the motor system and sensorimotor areas (Koenig 
et al., 2014). Thus, damage to circuitry and motor networks through characteristic atrophy 
may represent a key marker in HD neuropathology, and may help account for inter-individual 
variation and complexities in neuropathology. 
A number of studies have identified that structural changes to the striatum co-occur with 
functional difficulties in areas of cognitive, motor and neurological symptoms, suggesting 
fronto-striatal circuits mediate these processes as they become progressively dysfunctional. 
However, it is unknown whether direct (disease-related atrophy) or indirect effects of 
damaged tissues (CBF, metabolic processes) are responsible for these functional changes. 
Though dated, one previous study has shown that decreased resting CBF in the caudate 
correlated with decreased executive functioning performance (Berent et al., 1988). In pre-HD 
stages, cognitive performance on a range of measures correlates with caudate and putamen 
volume (e.g. Symbol Digits Modality Test, Stroop Interference, Verbal Fluency, Wisconsin 
Card Sorting Test, Towers Task, Trails B; Campondonico et al., 1998; Jurgens et al., 2008; 
Paulsen et al., 2010; Wolf et al., 2013) and white matter volume (Papp et al., 2013; Paulsen et 
al., 2010). There are inconsistent findings in the relationship to cortical volume loss, with 
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several positive (Novak et al., 2012; Wolf et al., 2013) and negative results (Harrington et al., 
2014; Rosas et al., 2005), suggesting cortical thinning may have more variable consequences 
for performance than striatal atrophy.  In symp-HD stages, caudate volume correlated with 
Mini-Mental State Examination score (MMSE; Harris et al., 1996), a general measure of 
cognitive impairment (Folstein et al., 1975); however, the MMSE has been criticised as 
insensitive to progressive dementia in other neurodegenerative diseases such as Alzheimer’s 
disease and frontotemporal lobar degeneration (Tan, Libon, Rascovsky, Grossman, & Xie, 
2013). This suggests that correlations with the caudate may reflect general impairment and 
may have little utility when repeated as a measure of disease progression. 
In addition to sensory/frontal pathways, the striatum is a critical hub in motor connectivity, 
with motor projections concentrated dorsolaterally (Jahanshai et al., 2015). Unsurprisingly, 
reduced striatal (dorsal) volume in pre-HD, measured using diffusion tensor imaging (DTI), 
has been associated with motor impairment on quantified neurological examination 
(Campodonico et al., 1998), and the presence of motor signs and symptoms in the Total 
Motor Score (TMS) index of the UHDRS (Aylward et al., 1994; Paulsen et al., 2006); 
however, it should be noted that the UHDRS shows floor effects due to its rating system (4 
point Likert Scale, rating 1-4, from “normal” to non-attempt or non-ability). Reduced 
putamen volume was found to relate to poorer psychomotor performance on Trails B and the 
Symbol Digit Modalities Test (Campodonico et al., 1998; Jurgens et al., 2008), complex 
psychomotor tasks which require planning (prefrontal) activation. During speeded tapping, 
variability of tap duration, inter-tap onset interval, and deviation from inter-onset interval 
were associated with bilateral atrophy to the caudate and putamen (more significantly on the 
right), with greater variability found in those with more grey matter atrophy (Bechtel et al., 
2010). Reduced left and right caudate volumes have been associated with motor task 
impairment in tongue force, greater antisaccade (inhibition of reflexive saccade, or eye 
movement) error rate, and slower metronome tapping (tapping in time to a stimuli, typically 
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auditory; Scahill et al., 2013) in a combined sample (pre-HD and early symp-HD), and in pre-
HD alone, with poorer scores in saccade velocity, finger tapping, tandem gait, and greater 
chorea associated with reduced striatal volume (Biglan et al., 2009). In a recent study of 
cortical structure and morphometry in older adults, deflation in the posterolateral aspect of 
the left caudate was associated with gait and balance impairment (MacFarlane et al., 2015). 
These authors identified no correlation with putaminal morphology and hypothesised that 
caudate deflation may impede prefrontal control of motor functioning rather than more 
obvious and direction motor effects of the putamen. Communication between hemispheres 
including the prefrontal regions determines regulation of electrophysiological premotor and 
motor activation.  Thus, the more subtle measures of motor activity as measured by EEG may 
show correlates to caudate morphology.  
To date, only one study has investigated electrophysiological-structural correlations. These 
authors found that later P300 latency, an endogenous potential representing decision making, 
was significantly associated with reduced caudate, putamen, and globus pallidus volume 
(Jurgen et al., 2011), supporting the notion that electrophysiological measures are sensitive to 
structural changes. If structural integrity of the striatum determines functional connectivity of 
motor pathways, circuit impairment may be detectable in electrophysiological responses. 
Striatal atrophy and obvious motor consequences may only be part of the story; Bartenstein et 
al (1997) demonstrated impaired striatal connectivity (with reduced frontal motor projections) 
during a voluntary motor task was also associated with enhanced parietal activity, an 
accessory motor pathway which may have maintained performance during early dysfunction. 
Pre-HD participants with minimal striatal atrophy and normal cognitive task performance 
show increased cortical activation (Paulsen et al., 2004; Reading et al., 2004; Wolf et al., 
2007). This may suggest excessive task-related cortical activation reflects recruitment of 
additional brain regions, and that this process is likely determined by connectivity of key 
fronto-striatal circuitry which may fail as structural integrity is compromised by the disease.
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1.6 Regions of Interest: The Corpus Callosum  
Although grey matter atrophy is well documented in HD, far less is known about white 
matter in the pathogenesis of HD.  Containing more than 200 million white matter fibres, the 
corpus callosum is the major commissure connecting inter-hemispheric grey matter tracts 
which are arranged topographically (e.g. anterior portions link to fronto-parietal cortices). 
Atrophy to the corpus callosum is common in HD (e.g. Crawford et al., 2013; Rosas et al., 
2010; Dumas et al., 2012), and may occur due to demyelination, axonal degeneration, or a 
combination of these factors (Bartzokis et al., 2007, Konrad & Winterer, 2008). Degeneration 
of the corpus callosum begins with thinning of fibre clusters and microstructural changes; this 
process is suggested to begin posteriorly and proceed anteriorly (Di Paola et al., 2012). This 
is likely due to the anatomical organisation of the fibres: posterior regions typically contain 
larger, earlier myelinated fibres, while the anterior contains smaller and late myelinating 
fibres (Aboitz, Scheibel, Fisher, & Zaidel, 1992). The anatomical progression of pathology 
suggests that earlier formation of the protective myelin sheath may actually represent 
enhanced vulnerability to pathogenic processes in HD. Myelin basic protein is dependent 
upon support of brain derived neurotrophic factor (BDNF), and mutant huntingtin degrades 
production of BDNF, which may result in reduced and/or unstable production of myelin (Di 
Paola et al., 2012; Phillips et al., 2013). These processes may compromise myelin, causing 
heavier myelin sheathed axons to break down prematurely, disrupting axonal coherence. 
Reduced axonal coherence impedes neuron communication in both segregated and ensemble 
networks, deranging grey matter tracts involved in both homotopic (e.g. parietal to frontal 
lobe) and heterotopic (e.g left and right frontal lobe) connectivity involved in motor control.  
Deterioration to the corpus callosum begins in pre-HD (Ciarmiello et al., 2006; Di Paola et 
al., 2012), with some suggestion white matter changes may have greater consequences for 
cognitive performance than grey matter (Beglinger et al., 2005). In symp-HD, global atrophy 
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to the corpus callosum is seen (e.g. Beglinger et al., 2005; Fennema-Notestine et al., 2004), 
whereas in pre-HD, loss of integrity is not spread over the entire network. Accordingly 
corpus callosum atrophy has been associated with reduced cortico-cortical connectivity 
(Rosas et al., 2010), and specifically with reduction in fronto-striatal networks that are 
involved in motor control, which begin in the pre-HD stage (Di Paola et al., 2012; Dumas et 
al., 2012). In studies using a baseline control group for volume, corpus callosum atrophy in 
pre-HD has been associated with poorer scores in finger tapping, antisaccades (latency and 
error), greater disease burden and increased probability of onset within 5 years (Dumas et al., 
2012), as well as poorer performance in cognitive tasks such as Stroop Word Reading 
(Crawford et al., 2013), suggesting that even partial reduction of connectivity has functional 
consequences.
 
1.7 How do Changes in the Striatum and Corpus Callosum affect Motor 
Functionality?  
1.7.1 Functional Motor Impairment 
Initiation, execution, inhibition, and termination of voluntary movement are affected in HD 
(Quinn, Hamel, Flanagan, Kaminski & Rubin, 1997; Sánchez-Pernaute et al., 2000; Smith, 
Brandt & Shadmehr, 2000). This is unsurprising given that HD is commonly considered a 
basal ganglia disease, and impairment reflects the anatomical and functional properties of the 
basal ganglia (Jahanshai et al., 2015). Persons with symp-HD show greater impairment than 
controls in simple motor tests (Saft, Andrich & Meisel, 2006) such as slowed and/or 
abnormal movements in tracing (Boulet et al., 2005; Carella et al., 2003; Lemay, Fimbel, 
Beuter, Chouinard & Richer, 2005), grasping (Bonfiglioli, De Berti, Nichelli, Nicoletti & 
Castiello, 1998; Quinn, Reilmann, Marder & Gordon, 2001; Schwarz, Fellows, Schaffrath & 
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Noth, 2001; Serrien, Burgunder & Wisendanger, 2001), aiming (Lemay, Chouinard, Richer 
& Lesperance, 2008; Smith, Brandt & Shadmehr, 2000), hand swapping tasks (Thompson et 
al., 2010), speeded tapping (Andrich, Saft, Ostholt & Muller, 2006), postural control (Medina 
et al., 2013), and gait control (Danoudis, 2014). However, it should be noted that only some 
of these classes of impairment are detected by the TMS subscore of the UHDRS, suggesting 
existing assessment tools are limited in scope and motor dysfunction is complex in its 
progress.  
In pre-HD, subtle motor changes have been found to be present in individuals who are not yet 
exhibiting the clinical observational motor criteria necessary for diagnosis (Kirkwood et al., 
2000; McCusker, Richards, Sillence, Wilson & Trent, 2000; Rao, Muratori, Louis, 
Moskowitz, & Marder, 2008), and recent evidence suggests that these impairments may 
precede other types of functional change (e.g. cognitive), and thus may represent more 
accurate clinical markers of disease progression. Over a 12-month period, Tabrizi et al (2011) 
found increasing deficits in pre-HD individuals compared with controls in motor tasks (such 
as circle tracing performance, motor grasping and chorea changes) but not executive 
functioning tasks (stroop test, symbol digit modalities, psychomotor speed, negative emotion 
recognition and smell recognition tests). In the largest pre-HD study to date (733 confirmed, 
196 controls), Biglan, Ross and Langbehn (2009) found an inverse association between the 
abnormality of individual motor scores, time to diagnosis and striatal volume. Greater 
abnormality and poorer response in tasks such as alternating hand movements, tandem gait 
movements and finger tapping were associated with smaller striatal volume and shorter 
proximity to diagnosis. An inverse relationship between motor performance and time to 
diagnosis has also been suggested in smaller studies (Farrow et al., 2006; Solomon, Stout & 
Weaver, 2008), suggesting that degeneration in the motor cortex and basal ganglia creates 
may create subtle motor impairment, however, there is generally minimal observable motor 
dysfunction present prior to symptomatic stages (see Figure 1.6).  
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Figure 1.6 Overview of progression of regional atrophy and motor impairment. Modified figure produced 
from data included in Bates et al. (2015) 
 
Quantifying subtle motor impairment in pre-HD may provide objective measures suitable for 
incorporation in clinical batteries (Bechtel et al., 2010). However, the failure of some 
longitudinal studies to identify motor performance decline over time suggests that the 
sensitivity of current tasks may be at present inadequate for marker use in pre-HD (Witjes-
Ane, Mertens, van Vugt, Bachoud-Levi, van Ommen & Roos, 2007). In addition, many 
motor tasks may not be practical in that they require specialised equipment or extended 
periods of testing which may be burdensome to individuals and expensive to run. Thus the 
refinement of quantitative motor tasks assessing simple movements is an important tool in 
HD research. 
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Self-paced finger tapping is a simple, reproducible, motor task designed to elicit a 
behavioural response without excessive cortical activation. The task involves an automatic, 
cyclical movement (finger oscillates between two targets), which has no termination 
requirement, lower attentional demands, and significantly less activation in the fronto-striatal 
systems than discrete motor tasks (Schaal, Sternad, Osu & Kawato, 2004). Tapping involves 
the striatum, pre and post central gyri, and supplementary motor areas (Carey et al., 2000), all 
of which are implicated structurally in symp-HD. Abnormal striatal connectivity may 
decrease motor cortex function, resulting in simple movement impairments. Accordingly, 
performance in speeded finger tapping has been demonstrated to worsen in HD individuals 
over a 3-year trial (Andrich, Saft, Ostholt & Muller, 2007). Pre-HD participants have also 
shown impairment in both speeded (as many taps as possible) and self-paced (continued taps 
in the absence of a metronome) tapping 15 years prior to diagnosis (Paulsen, Langbehn, 
Stout, 2008; Solomon, Stout & Weaver, 2008), and performance on both tasks has been 
demonstrated to decline over time (Rowe, Paulsen & Langbehn, 2010).  Structurally, tapping 
impairments in pre-HD have been associated with striatal atrophy (Biglan, Ross & Langbehn, 
2009; Paulsen, Langbehn & Stout, 2008), providing a potential link between function and 
anatomy.  
 
1.7.2 Functional Movement-Related Potentials (MRPs) 
Electroencephalography (EEG) may represent one means of investigating the integrity of 
motor performance at a neural level, and can be paired with simple motor tasks such as finger 
tapping. However, few studies in HD have utilised EEG to examine neural premotor 
processes. movement-related potentials refer to a segment of cortical electrophysiological 
activity locked to the preparation and/or execution of voluntary movement (Deecke, Scheid 
& Korhuber, 1969; Johnson et al., 2001). MRP’s reflect structural and connective changes in 
areas of the primary motor cortex, supplementary motor areas, and downstream in the 
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striatum (Johnson et al., 2001; Yazawa et al., 2000). This sensitivity suggests 
electrophysiology may be dependent upon critical fronto-striatal circuits, and thus show a 
relationship to the structural integrity of the striatum. In Study Two, this relationship will be 
clarified by examining correlations between components of electrophysiological premotor 
processing and structural measures of the caudate and putamen (volume and shape) obtained 
through manual tracing. Two functional motor electrophysiological measures relevant to 
known HD pathophysiology are discussed below: the Readiness Potential and the Contingent 
Negative Variation. 
 
1.7.2.1 The Readiness Potential (RP) 
Commonly known as the Bereitschaft Potential, the Readiness Potential (RP) is a slow-rise 
negative potential primarily seen at the vertex and symmetrically distributed over the scalp, 
beginning approximately 1-2 s prior to voluntary or imposed movement (Kornhuber & 
Deecke, 1965). Functionally, the RP represents neural processing in preparation for 
movement; it increases in slope approximately 400 ms prior to movement onset, and is 
maximal at the time of motor response (Deecke, Grozinger, & Kornhuber, 1976; Deecke, 
Scheuid, & Kornhuber, 1969; Kutas, & Donchin, 1980). At onset, the hemisphere activation 
contralateral to movement is greater than that of the ipsilateral hemisphere. The RP has been 
found have greater amplitude and earlier onset during sequential movements (Shibaski, & 
Hallet, 2006; Simonetta, Clanet, & Rascol, 1991). Reduced RP amplitude has been 
demonstrated in movement disorders such as Parkinson’s disease (Cunnington, Iansek, & 
Bradshaw, 1999; Ikeda et al., 1997), and similarly in conditions of cerebellar lesions 
(Shibasaki, Barrett, Neshige, Hirata, & Tomoda, 1986). Traditional tapping tasks used to 
elicit the RP involve an automatic, cyclical movement (the finger oscillates between two 
targets), and produce significantly less activation in fronto-striatal systems outside the 
sensorimotor cortex in contrast to discrete motor tasks (Bandettini, Wong, Hinks, Tikofsky, 
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& Hyde, 1992; Schaal, Sternad, Osu, & Kawato, 2004). In discrete motor tasks, such as self-
paced finger tapping, task complexity is minimised, allowing more accurate elicitation of 
motor and premotor potentials (Shibasaki & Hallett, 2006). Anatomically, tapping involves 
activity in the striatum, pre and post central gyri, and supplementary motor areas (Carey et 
al., 2000); MRPs reflect activation changes across regions of the primary motor cortex, 
anterior prefrontal cortex, parietal cortex, pre-supplementary and supplementary motor areas, 
and basal ganglia (Haggard, 2008; Yazawa et al., 2000). Neuronal atrophy in HD may 
progressively impair motor cortex function, disrupting fronto-striatal circuitry involved in 
motor control (Takakusaki, Oohinata-Sugimoto, Saitoh, & Habaguchi, 2004). To this end, 
electrophysiological premotor processing is likely a more subtle measure of motor 
dysfunction (e.g. timing, amplitude, and consistency of responses), and may show irregularity 
before functional impairment. 
Few studies have investigated the RP in HD populations; three have examined symptomatic, 
and only one has examined pre-HD (2009). For both real and imagined movement 
preparation during a guided finger tapping task, symptomatic individuals (symp-HD) 
demonstrated significantly reduced early slope, peak amplitude and post-peak slope in 
elicited RPs compared with controls (Johnson et al., 2001). In a follow-up study, early slope 
reduction in symp-HD was lessened (but still significantly reduced) when an attentional 
strategy was used to estimate cue timing and extinction (Johnson, Cunnington, Bradshaw, 
Chiu, & Iansek, 2002), suggesting that movement preparation deficits in symp-HD may be 
ameliorated by attentional control. In the only study evaluating the RP in pre-HD, Beste et al. 
(2009) also found significantly reduced peak amplitudes in symp-HD (but not pre-HD), 
compared with controls during finger taps. While amplitudes generated by pre-HD did not 
differ significantly from controls, increased inhibition in the hemisphere ipsilateral to the 
hand used in the task was identified (2009). The authors suggested this might reflect an active 
inhibition of alternative responses mediated by increased GABAergic neural transmission. 
1.7 How do Changes in the Striatum and Corpus Callosum affect Motor Functionality? 
 
- 33 - 
Unlike controls, in whom right hand response time was significantly shorter; pre-HD 
individuals were found to have no significant differences in hand reaction times. Beste et al. 
(2009) proposed this could indicate the contribution of additional processes which normalise 
task performance regardless of handedness. Although under-researched, these preliminary 
results suggest that, similar to performance measures, the physiological underpinnings (i.e. 
the RP) of movement may be obscured due to the masking effects of ancillary compensatory 
processes. Conversely, the ancillary processes themselves suggest a possible avenue for 
potential clinical measures of disease progression. 
 
1.7.2.2 Contingent Negative Variation (CNV) 
Contingent Negative Variation (CNV) is an MRP that provides an index of preparatory motor 
activation and sensorimotor integration. Like the RP, the CNV is a slow-wave negative 
potential generated in response to successive presentation of two contingent stimuli (Walter, 
Cooper, Aldridge, McCallum, & Winter, 1964). The first stimulus (S1) initiates preparatory 
sensorimotor integration, which is required for planning and/or execution of a motor response 
to the second stimulus (S2). The CNV is distinct from the neural motor programs, and thus 
provide a ‘cleaner’ index of the effort invested in the task than does the RP (as there is no 
movement artefact), and thus offers a useful means with which to address the compensation 
hypothesis proposed by Beste et al. (2009).  
The CNV response has been associated with structural substrates of the thalamus, putamen, 
globus pallidus, head of the caudate nucleus, supplementary motor area, motor cortex, 
orbitofrontal and mesial frontal areas, i.e. cortico-striato-pallido-thalamic (cortico-striatal) 
circuits (Bareš & Rektor, 2001; Drake, Weate, & Newell, 1997; Ikeda et al., 1996; Lamarche, 
Louvel, Buser, & Rektor, 1995; Rektor, Bareš, & Kubová, 2001; Rektor, Kaňovský, Bareš, 
Louvel, & Lamarche, 2001).  Only one study has investigated the CNV response in HD, and 
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no study has examined it in a pre-HD population, despite its potential utility in accessing 
premotor processing. These authors found that neural processing representing preparation for 
a second stimulus in a 2-stimulus array (early CNV) was significantly reduced in symp-HD 
compared with controls (de Tommaso et al., 2007), with amplitude negatively correlated with 
reaction time and motor signs (bradykinesia). While the authors suggested that reduced CNV 
amplitude might indicate decline in attention and arousal prior to motor responses, this would 
not be expected in pre-HD as there is very little evidence of attentional dysfunction until 
close to symptom onset. However, if motor impairments in pre-HD are being masked by 
compensatory processes, an increased CNV amplitude would be expected due to the greater 
effort required to perform the motor task relative to healthy controls
1.8 Study Rationales, Aims, Overviews, and Hypotheses 
1.8.1 Rationale for Study One  
HD causes significant and well documented neurodegeneration in the striatum, a hub 
providing afferent connectivity of premotor and motor circuits, as well as neurodegeneration 
in the corpus callosum, providing inter-hemispheric connectivity. Despite this early neuronal 
atrophy, pre-HD individuals show minimal differences in motor performance from healthy 
controls.  
Traditional motor tasks rely on clinical signs of observable impairment, such as in the current 
clinical tool used to measure HD severity, the TMS of the UHDRS (Huntington Study Group, 
1996). Clinical signs are often categorical in nature and therefore, may lack sensitivity to 
detect sub-clinical motor performance deficits in pre-HD. Studies identifying changes have 
been scarce, and restricted to studies with large sample sizes. Motor performance itself 
represents a behavioural output with limited temporal and spatial resolution; subcomponents 
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of the response remain inaccessible, and tasks may not be sensitive enough to detect early 
deficits or informative regarding the origin of the change. Additionally, relatively preserved 
motor performance may suggest that network despecialisation/compensation occurs in early 
stages of HD, which then serves to maintain functionality in a context of progressive 
neurodegeneration, where individuals are able to utilise ancillary neural resources to support 
motor performance.  
If motor execution is maintained through network despecialisation/compensation, then 
investigations should examine the integrity of premotor and motor responses. EEG may be 
more sensitive to assessing disruption of underlying neural function both before and after 
onset of voluntary movement in HD, especially to examine the integrity of the 
electrophysiological premotor and motor responses. If motor circuitry is compromised by 
neurodegeneration, disease-related impairment may be evident in the planning and 
preparatory stages of the motor response, rather than execution itself. Thus, the First Study 
presented in this thesis utilised EEG MRP measures of premotor and motor functioning (the 
CNV and RP, respectively) to investigate premotor and motor processing and functional 
compensation during finger tapping as a potential measure of disease progression and subtle 
premotor/motor impairment (Figure 1.7). 
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Figure 1.7 Schematic diagram illustrating context of Study One in overall thesis structure. 
 
1.8.2 Rationale for Study Two 
The results from Study One are presented in Chapter 2 and published in PLoS ONE (Turner 
et al., 2015). In summary, abnormal, relative premotor activation (CNV) was identified in 
pre-HD which was significantly different from controls and was not apparent in symp-HD. 
Relative amplitude was, and remained, heightened across the entire premotor period (early to 
late CNV). Persons with pre-HD did not differ in electrophysiological motor signals 
(readiness potentials) or execution (reaction times or response errors) from controls. It was 
hypothesised that abnormal premotor activation, in a context of intact performance, may arise 
from motor network compensation/despecialisation in the early stages of HD, despite 
neurodegeneration. Such ancillary processing is highlighted by over activation in subtle, 
electrophysiological motor preparation (the CNV), and may preserve function. If striatal 
atrophy does not result in performance consequences in pre-HD, despite irregular 
electrophysiological activation, and both electrophysiological and premotor/motor 
functionality are impaired in symp-HD, motor functionality is maintained in early stages of 
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the disease. This may occur through network despecialisation/compensation during early 
stages, before ancillary and circumventing processes fail as the disease progresses. If 
premotor activation alone is irregular, this may reflect early issues with functional 
connectivity of motor circuitry. Thus, electrophysiology may be dependent upon, and show 
correlates with, structural integrity of anatomical hubs of motor connectivity. 
 
 
Figure 1.8 Schematic diagram illustrating context of Study Two in overall thesis structure. 
 
1.8.3 Rationale for Study Three 
The breakdown of motor connectivity in HD likely reflects network despecialisation, which 
serve to maintain motor function despite grey and white matter loss. In Study Two, the 
electrophysiological premotor response was demonstrated to correlate with structural 
integrity of the striatum, suggesting fronto-striatal pathways involved in motor control 
progressively fail and begin with delayed, inefficient and inconsistent electrophysiology. 
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However, grey matter atrophy reflects only one component of the pathogenesis in HD. The 
corpus callosum instantiates distinct inter-hemispheric homotopic motor pathways (e.g. right-
left premotor cortex) which may potentially serve as ancillary networks either supporting, or 
delaying, dysfunction of connectivity in primary lateralised intra-hemispheric motor 
pathways such as the fronto-striatal premotor, motor, and dorsolateral circuits. Specifically, if 
atrophy to the corpus callosum begins posteriorly (and proceeds anteriorly), then the midline 
motor and premotor afferents in the caudate and putamen (Chao et al., 2009) may remain 
intact longer than more posterior circuits, and may serve to support motor processing. To 
date, no studies have been published investigating the relationship between corpus callosum 
atrophy and electrophysiological premotor function. However, white matter atrophy 
represents a distinct and promising avenue of research in elucidating functional motor 
connectivity. In Study Three, correlations between components of electrophysiological 
premotor processing (CNV; timing, consistency, and amplitude of response), and structural 
measures of white matter integrity (thickness of the corpus callosum) were examined in a 
combined HD sample.  
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Figure 1.9 Schematic diagram illustrating context of Study Three in overall thesis structure. 
 
1.8.4 Summary and Study Overview 
The search for a clinical marker in pre-HD is an international endeavour.  Despite well 
documented concentrated degeneration in regions such as the striatum, individuals in early 
stages of the disease present with minimal functional differences compared with healthy 
persons. This is particularly surprising given the striatum provides critical connections to 
premotor, motor and DLPFC circuits as well as subcortical structures (Jahanshai et al., 2015). 
EEG technology may enable detection sub-clinical differences in brain function and subtle 
changes in neural processes resulting from disruption to circuitry. Specifically, EEG enables 
us to detect changes in the early stages of motor planning, before any movement is enacted. 
Further, few functional changes have been reliably linked to volume and shape of the brain. 
Amalgamating structure and function will aid in understanding of the neuropathology of HD, 
and ways in which changes to fronto-striatal circuitry and subcortical morphology impact on 
neural pathways and disrupt function. 
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When combined with structural imaging, EEG informs us about the structural-functional 
integrity of specific neural circuitry involved in the pathophysiology of HD. Thus, while 
abnormal premotor neural activity may already be detectable in EEG studies, the combination 
of this research with imaging will provide a better understanding of the particular neural 
circuits which are impaired during the early stages of the disease, and how these relate to 
function. Considering concurrent early changes in structure and function is particularly 
relevant to HD, where no method is currently available to track disease progression prior to 
the appearance of behavioural symptoms, and where pathology is still poorly understood. We 
aim to investigate the relationship between the structural integrity of strategic components of 
the key neural circuits that subserve functional motor performance, and electrophysiological 
premotor activation. Specifically, we measured grey matter integrity (volume and shape of 
the striatum), as well as white matter (thickness of the corpus callosum). Identifying a 
composite measure of disease progression which unites structure and function may provide a 
means of assessing functional connectivity of motor circuitry.  
 
1.8.5 Hypotheses 
Study One 
Aim: To investigate whether disease-related compromise of structural integrity to crucial 
motor regions in HD affects electrophysiological motor function; the integrity of neural 
premotor and motor activation via the Readiness Potential and Contingent Negative 
Variation.  
Hypothesis: Presymptomatic (Pre-HD), Symptomatic (symp-HD) and controls will differ in 
premotor activation (with greatest amplitude in both early and late components of the CNV in 
controls, followed by pre-HD) 
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Study Two 
Aim: To explore neural substrates of premotor activation in HD by investigating volume and 
morphology of the caudate and putamen, critical regions in fronto-striatal circuitry involved 
in motor control.  
Hypothesis: Within a combined sample, increased premotor activation (as measured by CNV 
amplitude) would be associated with smaller volumes in the caudate and putamen and greater 
shape deflation (atrophy) in the lateral posterior caudate and putamen. 
 
Study Three 
Aim: To explore the relationship between premotor activation in HD and white matter 
thickness (corpus callosum), the major inter-hemispheric neural commissure and a critical 
hub in motor control. 
Hypothesis: Within a combined sample, premotor activation in HD would be correlated with 
corpus callosum profile thickness in mid-sagittal (mid-anterior) regions which provide 
homotopic connections to premotor, supplementary, and primary motor regions. 
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CHAPTER 2 – STUDY ONE 
ABNORMAL ELECTROPHYSIOLOGICAL MOTOR RESPONSES 
IN HUNTINGTON’S DISEASE: EVIDENCE OF PREMANIFEST 
COMPENSATION 
Is there electrophysiological premotor and motor dysfunction in HD? 
 
   
 
- 43 - 
Abnormal Electrophysiological Motor Responses in Huntington’s 
Disease: Evidence of Premanifest Compensation 
 
Lauren M Turner
1
, Rodney J Croft
2
, Andrew Churchyard
3,4
, Jeffrey C L Looi
5,6
, Deborah Apthorp
1,2
, 
Nellie Georgiou-Karistianis
3 
 
1
Research School of Psychology, College of Medicine, Biology, & Environment, Australian National 
University, Canberra, Australia 
2
School of Psychology & Illawarra Health & Medical Research Institute, University of Wollongong, 
Wollongong, Australia 
3
School of Psychological Sciences, Faculty of Medicine, Nursing and Health Sciences, Monash 
University, Victoria, Australia 
4
Calvary Health Care Bethlehem Hospital, Caulfield, Victoria, Australia 
5
Research Centre for the Neurosciences of Ageing, Academic Unit of Psychiatry and Addiction 
Medicine, Australian National University Medical School, Canberra Hospital, Canberra, Australia 
6
Melbourne Neuropsychiatry Centre, Department of Psychiatry, Faculty of Medicine, Dentistry and 
Health Sciences, University of Melbourne, Melbourne, Australia 
* Corresponding author 
E-mail: lauren.turner@anu.edu.au (LT) 
Running Title: Motor Compensation in Huntington’s Disease 
Word Count: Abstract: 246; Manuscript: 3426 
Figures: 2; Tables: 3; References: 42; Supplemental Information: 0 
Itemised Work Contribution: 
 LM Turner 80% (or more) - planning, designing, statistical analysis, interpreting 
results, writing first draft of paper, revising paper 
 RJ Croft 5% - interpreting results, comments on manuscript draft 
   
 
- 44 - 
 A Churchyard 1% - neurological testing 
 JCL Looi 4% - comments on manuscript draft 
 D Apthorp 7% - EEG analysis, comments on manuscript draft 
 N Georgiou-Karistianis 3% - planning, designing, comments on manuscript draft 
 
  
2.1 Study One: Abstract   
 
- 45 - 
ABSTRACT 
Background: Huntington's disease (HD) causes progressive motor dysfunction through 
characteristic atrophy. Changes to neural structure begin in premanifest stages yet individuals 
are able to maintain a high degree of function, suggesting involvement of supportive 
processing during motor performance. Electroencephalography (EEG) enables the 
investigation of subtle impairments at the neuronal level, and possible compensatory 
strategies, by examining differential activation patterns. We aimed to use EEG to investigate 
neural motor processing (via the Readiness Potential; RP), premotor processing and 
sensorimotor integration (Contingent Negative Variation; CNV) during simple motor 
performance in HD. 
Methods: We assessed neural activity associated with motor preparation and processing in 
20 premanifest (pre-HD), 14 symptomatic HD (symp-HD), and 17 healthy controls. 
Participants performed sequential tapping within two experimental paradigms (simple 
tapping; Go/No-Go). RP and CNV potentials were calculated separately for each group. 
Results: Motor components and behavioural measures did not distinguish pre-HD from 
controls. Compared to controls and pre-HD, symp-HD demonstrated significantly reduced 
relative amplitude and latency of the RP, whereas controls and pre-HD did not differ. 
However, early CNV was found to significantly differ between control and pre-HD groups, 
due to enhanced early CNV in pre-HD.  
Conclusions: For the first time, we provide evidence of atypical activation during 
preparatory processing in pre-HD. The increased activation during this early stage of the 
disease may reflect ancillary processing in the form of recruitment of additional neural 
resources for adequate motor preparation, despite atrophic disruption to structure and 
circuitry. We propose an early adaptive compensation mechanism in pre-HD during motor 
preparation.  
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INTRODUCTION 
Huntington’s disease (HD), a monogenetic, neurodegenerative disease, causes progressive 
motor, cognitive, and behavioural impairment (The Huntington’s Disease Collaborative 
Research Group, 1993). Symptom onset occurs in the 4
th
 decade of life; however, there is 
robust evidence of striatal and cortical atrophy up to 20 years prior to diagnosis (Aylward et 
al., 2012; Domínguez  et al., 2013; Georgiou-Karistianis et al., 2013a; Georgiou-Karistianis 
et al., 2013b; Tabrizi et al., 2009; Tabrizi et al., 2011; Tabrizi et al., 2013). Despite early 
neuropathological changes, individuals retain normal functions. Subtle cognitive and motor 
changes (e.g., tapping precision) have been shown to commence up to a decade prior to onset 
but progress at a slower rate than atrophy (Stout et al., 2011; Tabrizi et al., 2013). 
Specifically, observable motor impairment has been highlighted during more complex tasks 
(Farrow et al., 2006), which may implicate recruitment of ancillary regions to offset 
dysfunction in motor control. There is a growing interest in understanding the underlying 
brain mechanisms that enable individuals to function normally in the context of early 
degenerative processes. Structural degradation may be mitigated by neural compensation, 
which could support optimal performance during early stages of HD (Beste et al., 2007; Beste 
et al., 2009; Domínguez et al., 2013; Georgiou-Karistianis et al., 2013a; Georgiou-Karistianis 
et al., 2013b; Klöppel et al., 2009). Electroencephalography (EEG) provides a means of 
investigating functional impairment at the neuronal (ensemble) level, and offers an important 
opportunity to further investigate the mechanisms driving compensation (Papoutsi, 
Labuschagne, Tabrizi & Stout, 2014). In this context, EEG measures may also offer a new 
avenue for functional biomarker discovery where postsynaptic neural activity could be 
evaluated during early drug development. In this study, we focus on the temporal properties 
of neural ensemble activity characterising various elements of motor control.  
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Neuropathological changes, such as striatal volume loss, may have minimal functional 
consequences due to efferent and reciprocal connections between brain regions (Palop, Chin, 
& Mucke, 2006). That is, networks requiring coordination from multiple groups of neurons 
may maintain function despite localised damage. Previous functional magnetic resonance 
imaging (fMRI) studies have identified premanifest changes to neural networks, including 
reduced functional connectivity in cortico-striatal networks implicated in motor control  
(Georgiou-Karistianis et al., 2013b; Poudel et al., 2014a; Poudel et al., 2004b). Recently, 
decreased synchrony of sensorimotor networks was found to correlate with motor 
imprecision during speeded self-tapping, and to precede cognitive impairment in dorsal 
networks (Poudel et al., 2014a). This suggests that an impairment of motor circuitry may 
represent an early signature of disease progression. Cortical shifts, such as concurrent brain 
activation, may enable premanifest individuals to compensate effectively for early deficits in 
motor control, while still cognitively intact (Beste et al., 2007). 
Investigations of functional connectivity in motor control support recruitment of ancillary 
circuitry to supplement motor performance. For example, in symptomatic individuals (symp-
HD), reduced primary motor activation has been accompanied by parietal over-activation 
(Bartenstein et al., 1997; Gavazzi et al., 2007; Weeks et al., 1997) and in presymptomatic 
individuals (pre-HD) by excessive thalamo-cortical activation (Feigin et al., 2005). In 
particular, Klöppel and colleagues (2009) identified increased compensation in pre-HD 
individuals, involving flexible recruitment of premotor and parietal areas dependent on the 
pace and complexity of motor sequences. In studies with pre-HD, no between group 
differences have been identified in task performance, further suggesting the motor system is 
adept at re-organising itself according to task demands (Klöppel et al., 2009).  
Elicited from EEG, movement-related potentials (MRPs) provide a measure of cortical 
activity associated with movement preparation and execution (Ikeda et al., 1997). The 
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Readiness Potential (RP) represents movement preparation and is decreased in amplitude in 
movement disorders such as Parkinson’s disease (Cunnington et al., 1999; Ikeda et al., 1997). 
Reduced RP components have also been previously reported in symp-HD, compared with 
controls (Beste et al., 2009; Johnson et al., 2001; Johnson et al., 2002); however, in pre-HD 
no RP differences have been detected despite increased inhibition in the hemisphere 
ipsilateral to dominant hand which may reflect compensatory mediation by GABAergic 
transmission (Beste et al., 2007; Beste et al., 2009). In premotor activation, the Contingent 
Negative Variation (CNV) has also been found to be significantly reduced in symp-HD (de 
Tommaso et al., 2007); to date no CNV studies have been conducted in pre-HD.  
In this investigation, we aimed to evaluate neural motor mechanisms in both pre-HD and 
symp-HD, compared with healthy controls, using electrophysiological measures (i.e., RP and 
CNV). In doing so, we aimed to evaluate the neural compensatory hypothesis first proposed 
by Beste and colleagues (2009) in relation to ancillary motor control during a simple finger 
tapping task.  
 
MATERIALS AND METHODS 
Participants 
Forty-four participants were recruited for this study, consisting of 14 HD individuals (11 
males; symp-HD), 20 prodromal individuals (12 males; pre-HD), and 17 healthy controls (9 
males), age-matched to the pre-HD group. The EEG recording session entailed two tasks and 
participants with response amplitudes greater than -25 µV or excessive muscular artefacts 
were excluded. In Task 1 (cued and self-paced tapping), 7 participants were excluded, 3 pre-
HD (3 males), and 4 symp-HD (3 males); in Task 2 (sensorimotor integration), 3 participants 
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were excluded including 1 pre-HD (1 male), and 2 symp-HD (1 male). Participant 
demographics and clinical data for the overall sample are provided in Table 2.1. Pre-HD and 
symp-HD participants underwent genetic testing to confirm gene status and estimate CAG 
repeat length. Both HD groups of were assessed by a neurologist (A.C.) and underwent the 
Unified Huntington’s Disease Rating Scale (UHDRS; Huntington Study Group, 1996) as a 
measure of motor severity.  HD individuals with an UHDRS TMS (Total Motor Score) of < 5 
were included in the pre-HD group and those with scores of > 5 in the symp-HD group 
(consistent with TRACK-HD; Tabrizi et al., 2009). Formal ethics approval was granted by 
Monash University, with written informed consent was obtained from all participants. All 
clinical investigation was conducted according to the principles expressed in the Declaration 
of Helsinki.  
Neurocognitive testing included a speeded tapping task to assess motor performance (Hinton 
et al., 2007), Trails B to assess executive functioning (Tombaugh, 2004), and the Hopkins 
Verbal Learning Task (HVLT) to assess memory functioning (Brandt, 1992). Depressive 
symptoms were assessed using the Beck Depression Inventory-II (BDI-II; Beck, Steer & 
Brown, 1996).  
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Table 2.1 Demographic data for participants included in analyses of RP and CNV task. Standard 
deviations (SD) provided in parentheses. 
 Controls 
(n = 17) 
Pre-HD 
(n = 20) 
Symp-HD 
(n = 14) 
Gender (M:F) 9:8 12:8 11:3 
Age 41.00 (11.32) 41.11 (10.88) 58.64 (10.31)
a**b**
 
Education (yrs) 12.59 (2.10) 12.36 (2.31) 11.14 (2.71) 
CAG repeat length - 41.53 (2.50) 42.21 (1.97) 
CAG-index - 238.08 (101.88) 346.08 (68.26)
b**
 
Probability of Diagnosis 
in 5 years 
- 0.17 (0.20) - 
Illness Duration - - 4.07 (3.83) 
DBS - 239.39 (100.66) 387.82 (111.54) 
UHDRS  - 0.63 (1.16) 22.29 (10.62) 
IQ estimate 104.88 (27.76) 112.92 (6.03) 109.70 (7.03) 
BDI-II 2.12 (3.02) 7.16 (9.98) 8.14 (8.38) 
Trails B 61.30 (16.33) 67.73 (21.60) 166.79 (77.63)
a**b**
 
Speeded Tapping 186.25 (55.32) 218.61 (25.32) 362.45 (114.51)
a**b**
 
HVLT Total Recall 28.24 (3.87) 25.16 (4.89) 15.86 (7.01)
a**b**
 
HVLT Delayed Recall 10.06 (1.89) 8.89 (2.13) 5.50 (3.23)
a**b**
 
HVLT % Retention 88.46 (15.37) 88.78 (10.80) 78.17 (33.03) 
HVLT Recognition 
Discrimination Index 
11.53 (1.46) 9.89 (1.41)
a*
 7.93 (2.43)
a**b*
 
CAG, cytosine-adenine-guanine; CAG-index, [CAGn(# of CAG repeats) – 35.5]multiplied by age; probability of 
onset in 5-years; DBS, Disease Burden Score (CAG-35.5)*age; UHDRS, motor subscale score, Unified 
Huntington’s Disease Rating Scale (pre-HD, UHDRS <5; symp-HD, UHDRS ≥5); IQ (NART: National Adult 
Reading Test 2
nd
 Edition); BDI-II, Beck Depression Inventory – second edition; Trails B, Trail Making Test 
Two-Target-Switch; HVLT, Hopkins Verbal Learning Test. Independent samples t-test for differences between 
groups; * p < .05, ** p < .01; 
a
 significantly different from controls, 
b
 significantly different from pre-HD. 
Procedures 
EEG tasks  
As part of a larger study, participants completed a series of electrophysiological tasks. In 
order of presentation, these consisted of an EOG calibration task (Croft & Barry, 2000), a 
2.3 Study One: Method   
 
- 51 - 
cued and self-paced tapping task (Task 1), sensorimotor integration task (Go/No-Go 
paradigm; Task 2), working memory rehearsal, auditory and cognitive processing (oddball 
paradigm), face emotion processing, sustained attention task, with practice trials immediately 
prior to each task. Only the tapping and sensorimotor integration tasks are reported here.  
Cued and Self-Paced Tapping (Task 1) 
Participants performed a sequential tapping task on a response pad (Version 4.0; 
Compumedics, Neuroscan, TX, USA) using their right index finger. They were required to 
alternate between two buttons (left and right), at a rate of one every four seconds. The task 
comprised two Conditions (cued and self-paced). In the cued Condition, accompanying visual 
cues were provided by a square appearing on either the left or right of the screen. The cues 
were presented for 1000 ms, once every four seconds, for a period of 24 s. Participants were 
instructed to respond on the same side as the indicated cue as quickly as possible. In the self-
paced Condition, participants continued to press alternating buttons at the same rate in the 
absence of cues. The two Conditions alternated for a total of 8 minutes, resulting in a total of 
60-cued and 60 self-paced button presses in the task.  
Sensorimotor Integration (Task 2)  
Participants were presented with a 500 ms blue light flash (S1), followed 2.5 s later (fixed 
interval) by an ‘X’ or ‘Y’ visual cue (S2). S2-No-Go (Y) cues remained on screen for 1.9 s; 
S2-Go (X) cues remained on screen until a response. The ‘X’ stimulus was designated as a 
Go stimulus, requiring a motor response; the ‘Y’ stimulus was designated as a No-Go 
stimulus, indicating response should be withheld. Presentation of ‘X’ and ‘Y’ cues was varied 
randomly between the left and right sides of the screen, with location (of the ‘X’) indicating a 
corresponding button press of the ipsilateral key as quickly as possible using the right index 
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finger. A total of 90 trials were performed, with the No-Go stimulus occurring in 20% of 
trials. The inter-trial intervals were randomly varied between 2500 and 4000 ms. 
Electrophysiological Recording 
Presentation of stimuli and recording of behavioural responses were controlled by Stim2 
(Version 4.0; Compumedics, Neuroscan, TX, USA). EEG data were recorded and processed 
using Scan 4.1 (Compumedics, Neuroscan, TX) software. A 40-channel Lycra EEG cap with 
embedded tin surface electrodes was used, following the international 10/20 system. The 
EEG was referenced to a point midway between Cz and Pz, with a ground electrode located 
midway between Fz and FPz. Impedances were below 10 kΩ for all electrodes at the start of 
the recording. Eye movements (EOG) were measured for subsequent EOG correction, with 
electrodes placed above and below the left eye, and on the outer canthus of each eye. EEG 
and EOG signals were amplified using a NuAmps 40-channel DC amplifier (Compumedics, 
Neuroscan, TX) with a digital bandpass filter at 0.15-100 Hz, and sampled at 1000 Hz.  
Data Analysis 
Electrophysiological Data 
Readiness Potential (RP) - Cued and Self-Paced Tapping (Task 1) 
Off-line RP data were EOG-corrected (Croft & Barry, 2000), and bandpass filtered using a 20 
Hz (48 dB roll-off) to 100 Hz (12 dB roll-off) zero phase shift filter. The epoch segment 
comprised the period -2998 ms before to 1000 ms following movement execution (button 
press), with subsequent baseline correction (relative to -2500 to -2000 ms), artefact rejection 
procedures (±150µV; excluding EOG channels), and further removal of visually determined 
contaminated trials. Epochs were then averaged separately for each electrode site and 
Condition (i.e., cued and self-paced).  As RP amplitude was maximal at Cz, analysis was 
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restricted to this site. Participants with less than 15 epochs for a Condition were excluded 
from further analysis. The relative amplitude and latency of the RP respectively was 
computed using peak-to-peak values comprised of the difference between the negative peak 
occurring at -50 to 100 ms, and the positive peak 100 to 300 ms post response. Owing to 
inter-individual variability in activation, peak-to-peak values were used to provide a more 
accurate reflection of elevation from baseline during the RP than peak amplitudes, which may 
be affected by a range of factors including motivation during the task. 
Contingent Negative Variation - Sensorimotor Integration (Task 2) 
CNV data were EOG-corrected (Croft & Barry, 2000), and bandpass filtered using a 0.03 to 
35 Hz (24 dB roll-off) zero phase shift filter consistent with previous literature (de Tommaso 
et al., 2007). Data were epoched to the period of -3500 to 1000 ms relative to S2 (Go-No-Go) 
cue presentation and baseline corrected (relative to -3500 to -3000 ms). Artefact rejection 
procedures were automated (±150µV; excluding EOG channels), with additional rejection of 
contaminated trials based on visual inspection. Epochs were averaged separately for each 
electrode site; both Go and No-Go trials were included in the grand average. CNV 
Amplitudes were measured as maximum amplitudes obtained in the periods 550-750 ms 
following the presentation of S1 (early CNV; eCNV), and in the 200 ms prior to the onset of 
S2 respectively (late CNV; lCNV; de Tommaso et al., 2007). Peak-to-peak values were used 
to better account for inter-individual variation and degree of activation across the entire CNV 
profile (early and late peaks), rather than amplitude values. Values were calculated using the 
difference between the maximum amplitude obtained during the eCNV, and that of the 
lCNV. 
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Statistical Analysis 
For each task separately, each behavioural measure (reaction time, inter-tap intervals, inter-
tap interval variability), RP (amplitude, latency) and CNV component (early, late, difference) 
was examined separately (dependent variable) using a mixed design ANCOVA, with group 
(symp-HD; pre-HD; controls) the between-subjects factor and age a covariate. For Task 1, 
RP analyses contained a within-subjects factor Condition (cued; self-paced). For Task 2, 
early and late CNV values were initially taken at Cz. Subsequent exploratory analysis of sites 
Fz and Pz was based on prior studies (Ikeda et al., 1997), and was included to investigate 
possible abnormal activation in these sites (Bartenstein et al., 1997; Feigin et al., 2005; 
Klöppel et al., 2009). Bonferroni adjustments were used to control for multiple comparisons 
in all post-hoc testing. Pearson partial correlations (controlling for age) were used to examine 
the relationship between electrophysiological variables and clinical measures of disease 
progression for pre-HD and symp-HD groups.  
 
RESULTS 
Behavioural  
Behavioural results for Task 1 and Task 2 are presented in Tables 2.2 and 2.3 respectively. 
For Task 1 (cued and self-paced tapping), there was a significant main effect of Group for 
tapping variability (F (2, 40) = 6.691, p = .003), with symp-HD more variable than control (p 
= .003) and pre-HD (p = .008) groups. For Task 2 (sensorimotor integration) there was a 
significant main effect of Group for reaction time (F = 11.360, p < .001), with symp-HD 
(1306.66 ± 324) slower than controls (750.97 ± 203, p < .001) and pre-HD (779.11 ± 243.62, 
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p < .001) groups.  There was no difference in Go/No-Go errors between groups, with all 
groups responding accurately to each condition. 
Electrophysiological  
Readiness Potential (RP) - Cued and Self-Paced Tapping (Task 1) 
Table 2.2 displays peak and relative amplitude values and relative latency at Cz; grand 
average waveforms of the RP are shown in Figure 2.1. There was a significant main effect of 
Group for RP relative amplitude (F (2, 40) = 10.52, p < .001), with larger relative amplitudes 
for controls (-9.99 ± 4.58, p < .001) and pre-HD (-7.97 ± 3.17, p = .009) compared to symp-
HD (-3.51 ± 2.30). There was also a significant main effect of Group for relative latency (F 
(2, 40) = 3.35, p = .045); post-hoc analyses only identified a trend-level reduction in RP 
latencies for controls (-160.88 ± 61.35) compared to symp-HD (-209.56 ± 72.40, p = .052).  
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Figure 2.1 Tapping Task 1 (cued and self-paced Conditions). Grand average Readiness Potential (RP) 
waveforms are shown at Cz for each of the control, pre-HD and symp-HD groups. (A) cued tapping. (B) Self-
paced tapping. Time ‘0’ represents the time of motor response (right index finger button press).  
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Table 2.2 Electrophysiological and behavioural results for participants in the Tapping Task 1 (cued and 
self-paced Conditions). Amplitude and latency by at Cz, averaged across groups. Standard deviations (SD) 
provided in parentheses. 
 Controls 
(n = 17) 
Pre-HD 
(n = 17) 
Symp-HD 
(n = 10) 
Behavioural (Tapping)    
Time between taps    
Cued 4.47 (.035) 4.42 (.058) 4.53 (.080) 
Self-paced 4.12 (.118) 4.08 (.147) 4.17  (.359) 
Variability    
Cued .20 (.015) .28 (.036) .47 (.091)
a**b*
 
Self-paced .67 (.108) .69 (.125) 1.45 (.249)
a**b**
 
Electrophysiological (Amplitude/Latency)   
Cued    
Peak Amplitude -6.128 (6.57) -5.255 (4.73) -2.866 (7.96) 
Relative Amplitude -9.118 (4.22) -7.483 (3.53) -4.016 (1.91)
 a**b**
 
Relative Latency -164.23 (70.51) -193.41 (59.24) -190.80 (81.37) 
Self-paced    
Peak Amplitude -8.615 (5.47) -7.132 (5.94) -5.638 (8.74) 
Relative Amplitude -10.28 (4.95) -7.883 (2.81) -4.961 (2.70)
 a**b**
 
Relative Latency -158.11 (52.19) -174.94 (55.48) -226.40 (63.43) 
Relative amplitude and latency are computed based on the difference in peak values between the negative peak 
occurring -50 to 100ms prior to the motor response, and the positive peak 100 to 300 ms post response. Peak 
amplitude represents the negative peak occurring around time of response (-150 to 200 ms). Independent 
samples t-tests used for differences between groups, * p < .05, ** p < .01. 
a 
significantly different from controls,
 
b 
significantly different from pre-HD. 
 
 
Contingent Negative Variation - Sensorimotor Integration (Task 2) 
Peak and mean amplitudes of the eCNV and lCNV at Fz, Cz, and Pz for each group 
separately are shown in Table 2.3. CNV values at Cz constituted the main analysis, with 
values at Fz and Pz constituting an exploratory analysis. Grand average waveforms and 
exploratory topographic maps are provided in Figure 2.2. Typical grand mean distribution is 
observed with CNVs maximal at central scalp sites (Cz), and beginning approximately 1500 
ms prior to presentation of stimulus 2 (S2). Exploratory topographic maps suggest 
lateralisation of the early and late CNV in pre-HD. 
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Figure 2.2 Sensorimotor Integration Task/CNV waveforms. Grand average Go/No-Go waveforms at Fz, Cz 
and Pz across subjects; S1 and S2 are the warning and stimulus onset times respectively. Scalp topography maps 
represent mean amplitude of the CNV at early and late periods by group. Early CNV refers to the period 550-
750 ms following presentation of the warning light (stimulus 1); Late CNV refers to the period 200 ms prior to 
the onset of the Go/No-Go cue for button press (stimulus 2). 
 
There was a significant main effect of Group for eCNV peak amplitude (F (2, 44) = 4.697, p 
= .014), with symp-HD (-0.67 ± 3.65) amplitudes reduced relative to pre-HD (-7.23 ± 6.37, p 
= .026). No group differences were found for lCNV. However, examination of relative 
amplitude (early/late peak amplitude difference) revealed a significant main effect of Group 
(F = 4.190, p = .022), in which pre-HD relative amplitude (0.51 ± 5.47) was significantly (p = 
.018) smaller than that of controls (5.15 ± 4.04).  
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For the eCNV, peak amplitude at Pz was significantly different across groups (F (2, 44) = 
3.637, p = .035), with the difference between symp-HD (-0.16 ± 4.81) and pre-HD 
approaching significance (-5.08 ± 4.76, p = .056). In the lCNV, peak amplitude at Fz was 
significantly different among the groups (F = 4.298, p = .020); symp-HD (-0.03 ± 4.9) had 
significantly smaller amplitude than controls (-5.49 ± 4.94, p = .028) and pre-HD (-5.35 ± 
3.42, p = .030). At Pz, peak amplitude was significantly different across groups (F = 3.738, p 
= .032); symp-HD were significantly smaller than pre-HD (-1.80 ± 5.21 and -6.99 ± 5.49 
respectively, p = .040).  
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Table 2.3 Electrophysiological and behavioural results for participants in the Sensorimotor Integration 
Task 2. Amplitudes of early and late CNV by group at Fz, Cz, and Pz. Standard deviations (SD) provided in 
parenthesis. 
 Control 
(n = 17) 
Pre-HD 
(n = 19) 
Symp-HD 
(n = 12) 
Behavioural (Tapping)    
Reaction Time (ms) 750.97 (203.08) 779.11 (243.62) 1306.66  (324.12)
a**b**
 
Electrophysiological (Peak Amplitude/Area)  
Fz    
Peak Early CNV  -4.14 (2.85) -6.43 (7.49) -.231 (3.65) 
Peak Late CNV  -5.49 (4.94) -5.35 (3.42) -.034 (4.90)
ab*
 
Peak Difference 1.35 (3.53) -1.07 (5.87) -.197 (3.21) 
Area Early CNV -1.87 (3.06) -3.39 (5.13) 1.79 (3.09) 
Area Late CNV -3.89 (4.26) -3.27 (2.77) 1.61 (5.15)
ab*
 
Cz   
 
Peak Early CNV -3.55 (3.32) -7.23 (6.37) -.67 (3.65)
b* 
Peak Late CNV -8.70 (4.14) -7.75 (4.81) -3.68 (6.43)
 
Peak Difference 5.15 (4.04) .51 (5.47)
a*
 3.00 (4.49)
 
Area Early CNV -.946 (3.27) -4.21 (5.03) 2.03 (2.99)
b*
 
Area Late CNV -6.79 (3.59) -5.93 (4.56) -1.73 (6.07) 
Pz   
 
Peak Early CNV  -2.31 (2.90) -5.08 (4.76) -.163 (4.81)
b* 
Peak Late CNV  -6.83 (4.21) -6.99 (5.49) -1.80 (5.21)
b*
 
Peak Difference 4.53 (4.29) 1.91 (5.07) 1.64 (4.34) 
Area Early CNV .419 (2.77) -2.30 (4.05) 2.96 (3.80)
b*
 
Area Late CNV -4.94 (4.03)       -5.60 (6.69) -.066 (4.94) 
‘Peak amplitude’ refers to the maximum negative value in micro volts obtained within the early CNV or late 
CNV period, with early CNV defined as the period 550-750 ms following stimulus 1, and late CNV defined as 
the period in the 200 ms prior to stimulus 2. Area refers to the mean amplitude in micro volts during each 
respective CNV period, obtained separately for each electrode site, and is included to support peak amplitude. 
Independent samples t-tests used for differences between groups, * p < .05, ** p < .01. 
a 
significantly different 
from controls,
 b 
significantly different from pre-HD. 
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Correlational Analyses - Sensorimotor Integration (Task 2) 
For pre-HD, lCNV peak amplitude at Cz correlated with CAG repeats (.526, p = .025). For 
the symp-HD group, Pz lCNV peak amplitude correlated with CAG repeats (.636, p = .026), 
and DBS (.625, p = .030). Peak amplitude for both Fz eCNV (.608, p = .036) and lCNV 
(.645, p = .021) correlated with UHDRS motor score.  
 
CONCLUSIONS 
This study investigated neural motor and premotor processing during a simple motor task in 
Huntington’s disease. Symp-HD were significantly differentiated by behavioural measures 
(slower, more variable taps across tasks) and electrophysiological activity in both motor 
(smaller relative RP amplitudes) and premotor components (smaller early and late CNV 
peaks at Cz, and Fz and Pz respectively). Further, the late component at Pz was correlated 
with established measures of disease progression such as CAG repeats and DBS, supporting a 
link between aberrant motor processing and clinical degeneration. Consistent with our 
hypothesis, results indicated group differences between pre-HD and controls for premotor, 
but not motor measures. No behavioural variable (i.e., reaction time or tapping variability) or 
electrophysiological activity at time of response (i.e., RP) significantly differentiated pre-HD 
from controls, suggesting equivalent performance across groups. Importantly, premotor 
electrophysiological activity (the CNV) significantly differentiated pre-HD from controls, 
with more widespread electrical activation (Fz, Cz, Pz) and early and elevated preparatory 
motor activity. Aberrant electrical activity was further suggested by exploratory scalp 
topography, with partial lateralisation in pre-HD, but not control or symp-HD groups, across 
the CNV periods. Activation across frontal and parietal regions in pre-HD may suggest a shift 
in cortical motor control away from primary and secondary motor areas. As there was no 
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performance impairment, we argue that this increased activation may facilitate neural 
compensation, allowing cognitively intact pre-HD individuals to offset dysfunction 
(Domínguez et al., 2013; Georgiou-Karistianis et al., 2013a; Georgiou-Karistianis et al., 
2013b; Beste et al., 2007; Papoutsi et al., 2014). 
The RP, a well-established measure of motor activity, began approximately 2 seconds prior to 
the finger tap, occurring maximally at the vertex (Cz), and was largest in self-paced finger 
taps, within each group. We used peak-to-peak values to represent the difference in 
processing between the pre-movement negative peak, and the positive peak occurring after 
movement. Symp-HD significantly differed from controls and pre-HD groups in relative 
amplitude of the component, generating motor potentials which were smaller in amplitude in 
response to the button press. Relative latency also approached significance, with symp-HD 
responses longer than those of controls, particularly during self-paced tapping. As expected, 
the RP in pre-HDs did not differ significantly from controls or symp-HD groups. Disruption 
of the RP in symp-HD, but not pre-HD stages, is an important finding and may reflect 
increased inefficiency of the motor cortex with more time required to reach maximum 
amplitudes (which are significantly smaller than controls). Accordingly, this finding was 
accompanied by significantly slower reaction times in symp-HD. Accordingly, this finding 
was accompanied by significantly slower reaction times in symp-HD, but not response 
inhibition inaccuracy (No-Go errors). Breakdown of response inhibition has previously been 
found in symp and pre-HD (Beste, Saft, Andrich, Gold & Falkenstein, 2008; Beste, Ness, 
Falkenstein & Saft, 2011). The contrary findings to previous studies may be due to 
differences in our task parameters (e.g. cue prior to Go/No-Go stimuli, no timing feedback), 
which may interact with these complex processes to suggest maintained response inhibition 
accuracy in HD despite impairment. However, if response inhibition is intact, but reaction 
time impaired, this could suggest that costs of maintaining accuracy are also be reflected in 
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inefficient processing of the RP. Inefficient and inaccurate motor execution in symp-HD has 
been previously suggested by abnormal force, precision, range and velocity during motor 
tasks (Gordon et al., 2000; Quinn et al., 2001). The degree of structural degeneration in 
symp-HD may lead to an inability to recruit additional brain regions as part of a 
compensation process (Papoutsi et al., 2014). Regulation of the motor response itself may be 
impaired, as symp-HD have shown reduced ipsilateral inhibition and secondary, contralateral 
activation following normal contralateral MRP activation during a choice reaction task (Beste 
et al., 2009). This could also be related to disruption of hemispheric communication of the 
basal ganglia; for example, individuals with unilateral basal ganglia lesions demonstrate RPs 
with a reduced gradient in ipsilateral and contralateral hemispheres following wrist flexion 
with bilateral presentation (Fève , Bathien & Rondot, 1994). Compensation likely occurs 
across modalities; recruitment of additional brain regions in maintenance of performance has 
been previously identified in working memory, with increased, differential prefrontal 
activation identified in pre-HD in absence of performance detriment [Poudel et al., 2014a; 
Wolf, et al., 2008). The intactness of the neural motor response in pre-HD, coupled with no 
difference in reaction times compared with controls, support a likely functional compromise.  
For the premotor component (CNV), symp-HD demonstrated significantly smaller peak 
amplitudes at Cz and Pz compared to the pre-HD group; however, there were no significant 
differences in the early CNV at Cz between symp-HD and controls. This result is in contrast 
to Tommaso and colleagues (2007), who suggested that early CNV impairment represents an 
attentional impairment prior to execution of the motor response in symp-HD. We argue 
against this theory as symp-HD showed no significant difference in number of 
correct/incorrect responses during Go/No-Go (Task 2) performance, despite significantly 
slower reaction times. In the late CNV component, symp-HD had significantly reduced peak 
amplitude at Fz, compared with pre-HD and control groups. Peak amplitude at Pz was also 
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significantly reduced in symp-HD, compared to pre-HD, and positively correlated with CAG 
repeats and DBS in symp-HD. Tommaso and colleagues (2007) found no differences in late 
CNV, and proposed that this component may become reduced in later stages of the disease. 
This is plausible given that the prior study had an average illness duration of 2.9 years 
compared to an estimate of 4.1 years (sample sizes equal; SD = 12.96) in the present study. 
Reduced late CNV has been previously found in Parkinson’s disease and has been associated 
with dysfunction in the basal ganglia and associated thalamo-cortical circuitry (Ikeda et al., 
1997), and later in HD as a consequence of further degeneration. Moreover, in symp-HD 
peak amplitudes of late CNV at Pz were correlated with DBS and CAG repeats, at Fz with 
UHDRS motor score in, and in pre-HD Cz correlated with CAG repeats. The positive 
correlations may indicate a link between atypical network recruitment and progressing 
disease pathology. In both the early and late CNV, exploratory scalp topography suggested 
positive and aberrant activation in symp-HD, which may support increasing inefficiency of 
the motor system due to degeneration. However, considerable variance was apparent and 
likely reflects individual differences in disease progression, duration, and cognitive reserve.  
The CNV waveform typically appears as a negative, slow-rise slope (Ikeda et al., 1997). 
Unlike that of controls, the waveform of the pre-HD CNV was not maximal at Cz. 
Intriguingly, the waveform for pre-HD was higher in amplitude and flattened relative to 
controls and symp-HD, suggesting early, uniform activation, occurring consistently 
throughout the preparatory period between the two contingent stimuli. This difference 
between early and late CNV was significant only for pre-HD. The consistency of this 
waveform across Fz and Pz suggest a shift in cortical motor control involving the recruitment 
of additional brain regions. This may be reflected in scalp topography; lateralised activation 
was evident in both early and late CNV maps for pre-HD. Although not significant, the 
waveform difference at Cz trended towards significance in symp-HD, producing considerably 
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flatter CNV profiles than control counterparts. This likely reflects more significant and 
widespread neural dysfunction, which restricts resources and cognitive reserve which could 
otherwise enable task performance in the context of degeneration. Thus, CNV may represent 
a sensitive measure of disease progression in pre-HD.  
There are a few limitations of the study: the symp-HD group was not age-matched to healthy 
controls, and were significantly older and more male predominant than controls, as well as 
displaying more executive dysfunction. However, such findings are typical in a symp-HD 
group, and we controlled for these factors by including age and gender as covariates. 
Unfortunately, it is not practicable to partial out the effect of executive dysfunction. As 
mentioned, considerable variability was evident across individuals within groups in the RP 
and CNV results (i.e. within pre-HD). 
There were also clear differences in the CNV profile between both the early and late peaks 
for individuals. The decision to include peak to peak values was made after viewing the 
individual MRPs, not the group averages. When we viewed the group averages our decision 
was supported; it became evident that simply using measures of peak amplitude could not 
possibly capture group differences due to variability and the influence of other factors (such 
as motivation) on amplitude measures. When examining the CNV profile (Figure 2.2), it is 
clear that a measure of amplitude for early and late CNV would not distinguish pre-HD from 
healthy controls, despite clear differences in the profile of activation. We included peak to 
peak as a value to better capture the degree of activation across the potential, and efficiency 
of the premotor and motor systems in preparing for the task. 
In summary, this study replicated previous findings of no significant behavioural differences 
during motor task performance in pre-HD compared with controls (Campodonico et al., 1996; 
Farrow et al., 2006; Giordani et al., 1995; Klöppel  et al., 2009). Importantly, we identified 
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irregular premotor processing (CNV) in pre-HD, which involved more widespread activation 
during sensorimotor integration, despite intact motor processing (RP). This may support 
theory that during the early premanifest stages the brain may undergo a process of 
maintenance of cortical motor control, which involves recruitment of additional brain regions 
and networks to preserve function. Such compensatory mechanisms appear to be more 
heavily recruited during more cognitively demanding tasks. Performance intactness in the 
pre-HD group suggests compensation may be a reciprocal feedback process, employed to 
counterbalance dysfunction in response to unique processing demands. Overall, recruitment 
of ancillary circuitry in preservation of motor functions may represent a sensitive functional 
biomarker of disease progression in HD. Future studies in this area using techniques such as 
functional MRI, magnetoencephalography or standardized low resolution brain 
electromagnetic tomography may be able to further elucidate functional connectivity during 
neural premotor processing, such as the contributions of striatal networks. 
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CHAPTER 3 – STUDY TWO 
STRIATAL MORPHOLOGY CORRELATES WITH 
ELECTROPHYSIOLOGICAL MOTOR PROCESSING IN 
HUNTINGTON’S DISEASE: AN IMAGE-HD STUDY 
Does electrophysiological premotor dysfunction relate to striatal 
morphology? 
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ABSTRACT 
Background: Huntington’s disease (HD) causes progressive atrophy to the striatum, a 
critical node in frontostriatal circuitry. Maintenance of motor function is dependent upon 
functional connectivity of these premotor, motor, and dorsolateral fronto-striatal circuits, and 
structural integrity of the striatum itself. We aimed to investigate whether size and shape of 
the striatum, as a measure of frontostriatal circuit structural integrity was correlated with 
functional frontostriatal electophysiologic neural premotor processing (Contingent Negative 
Variation; CNV), to better understand motoric structure-function relationships in early HD. 
Methods: Magnetic resonance imaging (MRI) scans and electrophysiological (EEG) 
measures of premotor processing were obtained from a combined HD group (12 
presymptomatic; 7 symptomatic). Manual segmentation of caudate and putamen was 
conducted with subsequent shape analysis. Separate correlational analyses (volume and 
shape) included covariates of age, gender, intracranial volume, and time between EEG and 
MRI. 
Results: Right caudate volume correlated with early CNV latency over fronto-central 
regions, and late CNV frontally, whereas right caudate shape correlated with early CNV 
latency centrally. Left caudate volume correlated with early CNV latency over centroparietal 
regions and late CNV frontally. Right and left putamen volumes correlated with early CNV 
latency frontally, and right and left putamen shape/volume correlated with parietal CNV 
slope. 
Conclusions: Timing (latency) and pattern (slope) of frontostriatal circuit-mediated premotor 
functional activation across scalp regions was correlated with abnormalities in structural 
integrity of the key fronto-striatal circuit component, the striatum (size and shape). This was 
accompanied by normal reaction times, suggesting it may be undetected in regular tasks due 
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to preserved motor ‘performance’. Such differences in functional activation may reflect 
atrophy-based frontostriatal circuitry despecialisation and/or compensatory recruitment of 
additional brain regions. 
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INTRODUCTION 
Huntington’s disease (HD) is a progressive, autosomal dominant disease which results in 
widespread degeneration of cortical grey and white matter, as well as localised atrophy of the 
striatum (Hobbs & Barnes, 2010; Vonsattel & Myers, 1985). Although symptom onset 
typically begins around age 40 (Walker, 2007), neuroimaging demonstrates progressive 
atrophy up to 20 years prior (Aylward et al., 2012; Domínguez et al., 2013; Georgiou-
Karistanis et al., 2013; Tabrizi et al., 2009; Tabrizi et al., 2011; Tabrizi et al., 2013; van den 
Bogaard et al., 2011a,b). Involuntary motor dysfunction is a disease hallmark, reflecting 
damage to the basal ganglia. Symptomatic (symp-HD) individuals present with motor 
symptoms such as chorea (Nance et al., 2011) as well as detriment to initiation, execution and 
termination of voluntary movement (Boulet et al., 2005; Quinn et al., 2001; Lemay et al., 
2008; Smith et al., 2000). Despite neuronal degeneration, individuals in early stages (pre-HD) 
present with minimal functional differences compared with healthy persons (for example, 
they react quickly, and can perform simple tasks at the same speed). However, impairments 
have been detected during more complex motor tasks (e.g. Farrow et al., 2006; Georgiou-
Karistianis et al., 2014b), or in subcomponents of performance efficiency (e.g. increased 
tapping variability) within larger studies (e.g. Bechtel et al., 2010). Retention of motor 
functionality in pre-HD in the context of progressive atrophy is not well understood. One 
suggestion implicates functional connectivity: additional brain regions are recruited through 
reorganisation of fronto-striatal circuitry to counter early structural changes, compensatory 
processes which may fail with additional task demands and greater atrophy (Beste et al., 
2007; Beste et al., 2009; Domínguez et al., 2013; Georgiou-Karistianis et al., 2013; 
Georgiou-Karistianis et al., 2014a; Klöppel et al., 2009; Koenig et al., 2014). 
Electroencephalography (EEG) shows promise in identifying subtle changes in integrity of 
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motor processing, and may offer new insights into the mismatch between neural atrophy and 
successful motor performance (Turner et al., 2015). 
EEG has been suggested to be more sensitive to early disruption of cortical connectivity in 
HD than typical clinical measures (Lefaucheur et al., 2002), and shows promise in providing 
a measure of disease progression prior to observable motor deficits. EEG allows for the 
measurement of neural activity associated with sensorimotor integration and motor planning 
via the Contingent Negative Variation (CNV) (Ikeda et al., 1997). Such premotor function 
reflects cortical sources including the supplementary motor area (Macar et al., 2004) primary 
motor area (M1), and basal ganglia (Rektor et al., 2004). The early component of the CNV 
indexes prefrontal and supplementary sensorimotor areas (SSMA), the late the prefrontal, 
M1, primary sensory, temporal and occipital and SSMA areas (Hamano et al., 1997). As an 
index of complex premotor-related activation, the CNV may be capable of detecting subtler 
changes in motor processing resulting from changing structural integrity. For example, we 
recently demonstrated abnormal CNV in pre-HD (early, over-engagement of premotor 
processes that were less focused than controls and occurred across electrode sites), despite 
intact motor processing (as measured by the Readiness Potential; RP) and normal reaction 
times (Turner et al., 2015). This irregular CNV activation may reflect changes in functional 
connectivity: i.e. damage to the striatum compromises the underlying structural integrity of 
motor, premotor, and dorsolateral prefrontal cortex circuit loops, impairing hemispheric 
interactions and premotor processing. 
Premotor and motor activation rely on parallel and converging circuitry traversing both brain 
hemispheres (Alexander et al., 1989). The striatum represents a critical node in a number of 
fronto-striato-pallido-thalamo-cortical re-entrant circuits which regulate cognitive, emotional, 
and behavioural as well as motor functions (Draganski, 2008). Based on the fronto-striatal 
circuit model (Alexander et al., 1986), a number of studies have shown preferential 
 3.2 Study Two: Introduction
 
- 75 - 
localisation of motor control to the dorsolateral prefrontal cortex (DLPFC), premotor and 
motor loop circuits (e.g. Lehéricy et al., 2004; Taniwaki et al., 2003; Utter & Basso, 2008). 
The DLPFC can be thought of as a “cognitive loop”, which underpins executive functioning 
(Alexander et al., 1986; Cummings, 1993). The striatum is highly topographically organised 
based on afferents from the cortex (Bohanna et al., 2011) (see Figure 3.1). Structural changes 
in the striatum are thus one possible mechanism by which the CNV may be affected in HD, in 
that loss of structural integrity may disrupt fronto-striatal circuits involved in motor control, 
prior to the onset of clinical motor sequelae. One avenue of research that may clarify this 
issue is by linking electrophysiological measures of premotor activation (CNV) with 
structural MRI measures of striatal morphology. 
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Figure 3.1 Striatal afferent connections: surface regions of the striatum which receive afferents from 
respective regions of cortex. Reproduced with permission from Looi et al. (2011). PMC, premotor cortex; MC, 
motor cortex; DLPFC, dorsolateral prefrontal cortex; OFC, inferior orbitofrontal cortex; ACC, anterior cingulate 
cortex; MPFC, medial prefrontal cortex. 
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Recently, functional magnetic resonance imaging (fMRI) studies have implicated functional 
connectivity changes in pre-HD,  including fronto-striatal networks implicated in motor 
control (Koenig et al., 2014; Georgiou-Karistianis et al., 2013; Georgiou-Karistianis et al., 
2013b; Poudel et al., 2014a; Poudel et al., 2014b; Unschuld et al., 2012). Weakened M1 
connectivity with the supplementary motor area and DLPFC was found only in pre-HD 
individuals temporally distant from onset of symptoms (Wolf et al., 2012), suggesting that 
reorganisation may be a dynamic process depending on disease stage and the availability of 
neural resources. Klöppel et al (2009) identified increased compensation in pre-HD 
individuals, involving flexible recruitment of premotor and parietal areas, dependent on the 
pace and complexity of motor sequences. Reduced primary motor activation has been 
accompanied by parietal over-activation in symp-HD (Bartenstein et al., 1997; Gavazzi et al., 
2007; Weeks et al., 1997) and by excessive thalamo-cortical activation during motor 
sequence processing in presymptomatic individuals (pre-HD) (Feigin et al., 2005). Further, 
reduced sensorimotor network synchrony occurs prior to cognitive impairments in dorsal 
networks and has also been associated with performance deficits, such as imprecision during 
speeded self-tapping (Poudel et al., 2014a). Reduced connectivity of M1 both within and 
outside the motor network has been associated with reduced motor performance, greater 
motor symptoms and striatal atrophy, and may reflect compensatory reorganisation of 
function as well as decreased preferential connectivity (specialisation) in pre-HD (Koenig et 
al., 2014). Combining an electrophysiological measure of premotor activation (CNV) with 
structural MRI will enable investigation of subtle components of motor response, and their 
relationship to striatal morphology. A better understanding of the structural-functional 
integrity specific to the neural circuitry impaired during the disease will inform our 
understanding of the function and pathophysiology of HD, such as possible network 
despecialisation/compensation through progressive atrophy.  
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In this study we sought to explore neural substrates of abnormal premotor activation in HD 
(as measured by the CNV) identified in our previous paper (Turner et al., 2015). There are 
two key reasons to investigate the striatum, based on putative alterations in fronto-striatal 
circuit structure and function, as reflected by CNV. First, there is a neuroanatomical 
rationale, based on striatal atrophy in HD and the localisation of fronto-striatal motor 
afferents to the caudate head and body, as well as the medial and lateral aspects of the 
putamen (Draganski et al., 2008; Haber et al., 2003). This rationale predicts that disease 
progression will undermine fronto-striatal motor connectivity. Second, there is preliminary 
evidence that changes in fronto-striatal functional connectivity occur early in disease 
processes and may enable compensation. Hence, integrative examination of structure-
function correlations may yield new insights into mechanisms of maintenance of function. 
Based upon the preceding, we hypothesised: (1) that an abnormal CNV would be associated 
with reduced structural integrity of the key fronto-striatal circuit components, caudate and 
putamen, as measured by morphology (Looi & Walterfang, 2013); and (2) as the CNV 
requires premotor and motor activation, morphometry (quantification of the shape) of the 
striatum will likely demonstrate atrophy (shape deflation) in the lateral posterior caudate and 
putamen structures, reflecting reduced functional connectivity of the dorsolateral prefrontal, 
motor, and premotor fronto-striatal circuits.  
In order to investigate our hypotheses, both CNV and structural MRI data were obtained from 
a group of HD participants. To maximise statistical power and account for within-group 
variability in disease burden score (DBS), CAG repeats, and disease onset, we included both 
presymptomatic (pre-HD) and symptomatic individuals (symp-HD) in our sample. We 
hypothesised that increased CNV amplitude, representing neural premotor processing during 
a sensorimotor integration task would be associated with smaller volumes (indicating more 
atrophy) in the caudate and putamen. 
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METHODS 
Acquisition Procedures 
Participants 
Participant data were obtained in 2008-2009 as part of the IMAGE-HD project (Georgiou-
Karistianis et al., 2013), with EEG and MRI data collected on different days. Time periods 
between EEG testing and MRI were computed for each individual (‘Time to Scan’), and used 
as a covariate in all analyses. Participants consisted of 7 genetically-confirmed HD 
individuals (5 males; symp-HD), and 12 genetically-confirmed prodromal individuals with no 
clinical manifestations (7 males; pre-HD). This represents the entire HD sample reported in 
Turner et al (2015) that also completed the imaging portion of the study (and that had usable 
data). All participants provided consent to participate in EEG and imaging studies and were 
assessed by a neurologist (A.C.). Ethics approval was obtained from the Melbourne Health 
Human Research Ethics Committee and for image analysis, the ANU Human Research Ethics 
Committee. Research procedures complied with the Code of Ethics of the World Medical 
Association (Declaration of Helsinki). 
Clinical, Neuropsychiatric and Cognitive Measures 
In addition to EEG and MRI data collection, a range of clinical, neuropsychiatric and 
cognitive measures were collected. Participant demographics and clinical data are displayed 
in Table 3.1; only measures relevant to the present paper are reported below. We display 
between group data to show sub-group characteristics are similar to those reported in the 
literature, and discuss these briefly here. In order to characterise the groups, HD individuals 
with an UHDRS [Unified Huntington’s Disease Rating Scale; (1996)] total motor score of 5 
or less were included in the pre-HD group and those with scores greater than 5 in the symp-
HD group (Tabrizi et al., 2011). Non-parametric Mann-Whitney U tests indicate that as 
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expected, symp-HD had right and left caudate and putamen volumes that were significantly 
smaller than pre-HD. Symp-HD were also significantly older (p = .045), and scored 
significantly more poorly on Trails B p = .005; 158.00 ms and 73.96 ms), speeded finger 
tapping (p < .001; 335.53 and 215.86), reaction time during the CNV task (p <  .05; 1272.94 
and 820.17) and the Unified Huntington’s Disease Rating Scale Total Motor Score (p < .001). 
These results are as expected given the level of disease progression in these individuals. As 
our aim was to combine genetically-confirmed individuals into one group for increased 
power, between group data will not be discussed elsewhere in the manuscript. 
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Table 3.1 Demographic data between groups and in overall sample (ALL-HD). 
Mean ± SD 
 Pre-HD (n = 12) Symp-HD (n = 7) ALL-HD (n = 19) 
Demographics    
Gender (M:F) 7:5 5:2 12:7 
Age 42.16 ± 12.14 (24, 64) 51.57 ± 8.56 (41, 65)
*
 46.58 ± 12.25 
Education (yrs) 11.83 ± 2.28 11.57 ± 2.63 11.73 ± 2.35 
CAG  42.16 ± 2.72 42.57 ± 1.51 42.31 ± 2.31 
ICV  1425.24 ± 170.82 1429.82 ± 120.14 1426 ± 150.50 
Time to Scan -40.33 ± 108.73  
(-242, 105) 
-276.28 ± 70.70  
(-364, -174)
*
 
-127.26 ± 150.22 
(-364, 105) 
Probability of Diagnosis  0.21 ± 0.23 - - 
Illness Duration - 1.42 ± 0.78 - 
DBS 269.00 ± 104.42 408.92 ± 142.04
**
 320.55 ± 134.90 
UHDRS  0.33 ± 0.65 (0, 2) 17.42 ± 8.32 (11, 33) 6.63 ± 9.75 
IQ Estimate 112.90 ± 5.48 110.82 ± 7.00 112.13 ± 5.98 
BDI-II 6.75 ± 7.60 3.85 ± 3.57 5.68 ± 6.45 
Trails B 73.96 ± 23.63 158.00 ± 94.01
**
 104.92 ± 70.86 
Speeded Tapping 215.86 ± 12.65 335.53 ± 100.04
**
 259.96 ± 83.37 
HVLT Total Recall 24.91 ± 4.29 18.71 ± 9.12 22.63 ± 6.96 
HVLT Delayed Recall 8.75 ± 1.91 7.28 ± 3.63 8.21 ± 23.25 
HVLT % Retention 87.45 ± 10.46 88.72 ± 37.67 87.92 ± 23.25 
HVLT Recognition 
Discrimination Index 
10.25 ± 1.21 9.00 ± 2.70 9.79 ± 1.93 
Reaction Time (CNV) 820.17 ± 268.94 1272.94 ± 382.69
*
 971.09 ± 371.63 
Volume (mm
3
)    
Right Putamen 2692.88 ± 505.79 1673.83 ± 226.60
**
 2317.44 ± 654.61 
Left Putamen 2682.02 ± 579.64 1703.18 ± 192.96
**
 2321.40 ± 673.10 
Right Caudate 3265.68 ± 662.22 2180.11 ± 199.59
**
 2865.74 ± 755.45 
Left Caudate 3208.72 ± 711.01 2115.84 ± 156.22
**
 2806.08 ± 781.30 
CAG, cytosine-adenine-guanine; ICV: Intracranial volume; IQ (NART: National Adult Reading Test 2
nd
 
Edition); time to scan computed in days from EEG baseline to MRI; probability of onset in 5 years calculated 
from Langbehn et al (2004); Disease Burden Score (CAG-35.5)*age; UHDRS, motor subscale score, Unified 
Huntington’s Disease Rating Scale (pre-HD, UHDRS <5; symp-HD, UHDRS ≥5); predicted Full Scale IQ 
converted from performance on the National Adult Reading Scale. Non-parametric Whitney Mann U tests for 
differences between groups; * p < .05; ** p < .01.  
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Electrophysiological recording and analysis 
Presentation of stimuli and recording of behavioural responses were controlled by Stim2 
(Version 4.0; Compumedics, Neuroscan, TX, USA). EEG data were recorded and processed 
using Scan 4.1 (Compumedics, Neuroscan, TX) software. A 40-channel Lycra EEG cap with 
embedded tin surface electrodes was used, with 40 recording electrodes placed according to 
the international 10/20 system. The EEG was referenced to a point midway between Cz and 
Pz, with a ground electrode located midway between Fz and Pz. Impedances were below 10 
kΩ for all electrodes at the start of the recording. Eye movements (EOG) were measured for 
subsequent EOG correction, with electrodes placed above and below the left eye, and on the 
outer canthus of each eye. EEG and EOG signals were amplified using a NuAmps 40-channel 
DC amplifier (Compumedics, Neuroscan, TX) with a digital bandpass filter at 0.15-100 Hz, 
and sampled at 1000 Hz. Data was stored off-line for later processing. 
Contingent Negative Variation (CNV) Task 
A Go/No-Go Task was employed to elicit electrophysiological components of sensorimotor 
integration (CNV). All participants were right handed and elected to use their dominant hand 
during the motor task. A 500 ms warning stimuli was presented (blue light flash; S1), 
followed 2.5 s later by an ‘X’ or ‘Y’ visual cue (S2), appearing randomly on either the right 
or left side of the screen. Participants were instructed to respond only to the ‘X’ stimulus and 
to press a button corresponding to its position on the screen. The No-Go stimuli occurred in 
20% of trials, and the inter-trial interval was randomly varied between 2500 and 4000 ms 
across a total of 90 trials. 
 
 
 3.3 Study Two: Methods
 
- 83 - 
Imaging 
Structural MRI images were acquired using a Siemens Magnetom Tim Trio 3 Tesla scanner 
(Siemens AG, Erlangen, Germany), with a 32-channel head coil at the Murdoch Children’s 
Research Institute (Royal Children’s Hospital, Victoria, Australia). High resolution T1 
weighted images were taken (192 slices, 0.9 mm slice thickness, 0.8 mm in-plane resolution, 
TE = 2.59 ms, TR = 1,900 ms, flip angle = 9°). 
Data Analysis 
Electrophysiological data 
The CNV was filtered using a 0.03 to 35 Hz bandpass zero phase shift filter (24 dB roll-off) 
consistent with literature and our previous study (de Tommaso et al., 2007, Turner et al., 
2015). The CNV was epoched to the period of -3500 to 1000 ms respective to S2 (Go-No-
Go) cue presentation.  Epochs were baseline corrected (relative to -3500 to -3000 ms) and 
averaged separately for electrode site. We used automated artefact rejection procedures 
(±150µV; excluding EOG channels), accompanied by rejection of contaminated trials by 
visual inspection. Both Go and No-Go trials were included in the grand average, and 
participants with less than 15 epochs were excluded from analysis. 
Early and late CNV values were obtained from sites Fz, Cz and Pz. Selection of electrode 
sites was made a priori, and aimed to mirror both our previous study (Turner et al., 2015), as 
well as prior studies suggesting possible abnormal activation across these sites (Bartenstein et 
al., 1997; Feigin et al., 2005; Gavazzi et al., 2007; Ikeda et al., 1997; Klöppel et al., 2009; 
Weeks, Ceballos-Baumann & Piccini, 1997). We derived early and late CNVs as peak 
amplitudes during the epoch -2450 to -2250 ms, and -200 to 0 ms respectively (de Tommaso 
et al., 2007). The relative amplitude of the CNV was computed using peak-to-peak values 
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comprised of the difference between the peak during the early CNV and that of the late CNV. 
We used the polyfit function in MATLAB
™ 
to fit a regression slope for each participant, 
calculating slope average and goodness of fit. Regression slopes were calculated for main 
electrode sites Fz, Cz, and Pz. 
Volume Analysis  
Striatal volumes (caudate and putamen) were obtained by a single trained researcher 
(F.A.W.) by manual tracing following a validated protocol (intra-rater intra-class correlation 
0.88 - 0.98) using ANALYZE 11.0 (Mayo Foundation, Rochester, MI, USA) software. 
Protocol details are available elsewhere (Looi et al., 2008).  This manual tracing yields binary 
shapes for the structures. Intracranial Volume (ICV) was calculated using FSL’s Brain 
Extraction Tool (Smith & Stephen, 2002). FSL is freely available for non-commercial use 
and can be obtained from FMRIB’s Software Library (http://fsl.fmrib.ox.ac.uk/fsl/fslwiki/). 
Shape Analysis 
Shape analysis procedure replicated a previous study (MacFarlane et al., 2015). Shapes were 
analysed in a semi-automated manner using the University of North Carolina shape analysis 
toolkit (http://www.nitrc.org/projects/spharm-pdm/), full details of which are available 
elsewhere (Leavitt et al., 2009; Styner et al., 2006). Segmented three-dimensional binaries are 
initially processed to ensure interior holes are filled, followed by morphologic closing and 
minimal smoothing. These are then subjected to spherical harmonic shape description, 
whereby boundary surfaces of each shape are mapped onto the surface of a sphere and the 
surface coordinates were represented through their spherical harmonic coefficients 
(Brechbühler et al., 1995). The correspondence between surfaces is established by parameter-
based rotation, itself based on first-order expansion of the spherical harmonics. The surfaces 
are uniformly sampled into a set of 1,002 surface points and aligned to a study-averaged 
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template for each structure (left and right caudate and putamen) using rigid body Procrustes 
alignment (Bookstein, 1996). Scaling normalisation was performed to remove the effect of 
head size/ ICV, using a surface scaling factor: fi, where fi = {Mean (ICV)/ICV I 
1/3
}. (Styner 
et al., 2007).  
Statistical analyses 
All statistical analyses were performed using SPSS statistical software version 20.0 (IBM 
SPSS Statistics, Chicago). The data were initially divided into pre-HD and symp-HD samples 
for the purposes of volumetric comparisons to describe the characteristics of the subgroups. 
Non-parametric Mann-Whitney U tests were used to examine between group differences in 
volume estimates of the left and right caudate and putamen regions. Non-parametric 
Wilcoxon signed rank tests were used to examine within-group differences in caudate and 
putamen volumes between hemispheres for each group (pre-HD, symp-HD) and the 
combined group (ALL-HD). 
Correlational analyses for volume and shape (morphology) were conducted on the combined 
group (ALL-HD) to increase sample size, statistical power and account for individual 
differences in disease progression. All correlational analyses used age, gender, ICV, and time 
to scan as covariates. For volume, Pearson partial correlations were used to examine the 
relationship between volume estimates (left and right caudate and putamen) and 
electrophysiological, clinical, and behavioural variables. For shape, Pearson’s partial 
correlation was used to determine variable relationships between morphology (left and right 
caudate and putamen), based on distance of surface points from an average shape (Levitt, 
2009; Styner et al., 2006). Electrophysiological variables consisted of amplitude, relative 
amplitude, latency, and slope estimates of the CNV at Fz, Cz, and Pz. Clinical variables 
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included disease burden score, CAG repeats and Trails B scores. Behavioural variables 
included reaction time derived from the CNV task. 
 
RESULTS 
The CNV 
Grand average waveforms of the CNV are shown in Figure 3.2. Typical grand mean 
distribution is observed with CNV maximal at central scalp sites (Cz), and beginning 
approximately 1500 ms prior to presentation of stimulus 2 (S2). 
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Figure 3.2 Grand average waveforms of the Contigent Negative Variation (CNV) at Fz, Cz, and 
Pz; S1 and S2 are the warning and stimulus onset times respectively. Early CNV refers to the period 
550-750 ms following presentation of the warning light (stimulus 1); Late CNV refers to the period 
200 ms prior to the onset of the Go/No-Go cue for button press (stimulus 2).  
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Volume and shape analyses 
Age, gender and ICV were used as covariates in volume and shape analyses. Symp-HD 
demonstrated significantly smaller volumes than pre-HD of both caudate (right and left p < 
.001) and putamen (right p = .004, left p = .010). Non-parametric Wilcoxon signed rank tests 
failed to demonstrate any significant differences in volumes between hemispheres for any 
group, or the combined group (ALL-HD). Relationships between striatal shape and 
electrophysiological and behavioural variables were examined; to account for sample size 
and inter-individual variability in disease progression, the pre-HD and symp-HD group were 
combined in analyses to increase statistical power (ALL-HD).
1
 
Volume correlations with CNV latency, amplitude, and relative amplitude are shown in Table 
3.2. For behavioural variables, reaction time was significantly correlated with right putamen 
volume only (-0.605, p = .022). Speeded tapping, a clinical test, was significantly correlated 
with right caudate volume (-.540, p = .046). Trails B score was significantly correlated with 
right (-.593, p = .025), and left caudate volumes (-.555, p = .039), as well as the right 
putamen (-.540, p = .046). 
Shape correlations for the early CNV latency at Cz and the CNV slope at Pz are presented in 
Figures 3.2 and 3.4, respectively. Latency of the early CNV component at Cz was negatively 
correlated with shape in both medial (centralised) and lateral (anterior and posterior; patchy) 
aspects of the right caudate. Shape deflation was most notable in negative correlations 
between CNV slope at Pz in the medial and lateral aspects of the right putamen (medial; 
central; lateral; anterior and posterior), and left putamen (medial and lateral; widespread); 
most of this shape deflation was seen on the dorsal aspect of the putamen on both medial and 
lateral sides. 
                                                          
1
 A table of partial correlations between groups (pre-HD and symp-HD) is included for the reader’s interest in 
Supplementary Materials.  
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Table 3.2 Partial correlations between caudate and putamen volume and amplitude, relative amplitude 
(slope) and latency of electrophysiological motor component (CNV) 
 Caudate Putamen 
 Right Left Right Left 
Amplitude     
Early     
   Fz  -.424 -.506 -.264 -.269 
   Cz  -.340 -.410 -.194 -.151 
   Pz  .0709 .035 -.088 .058 
Late     
   Fz  -.313 -.292 -.387 -.262 
   Cz  -.240 -.329 -.015 -.077 
   Pz  -.041 -.013 -.344 -.175 
     
Latency     
Early     
   Fz -.666
**
 -.436 -.704
**
 -.629
*
 
   Cz -.691
**
 -.651
*
 -.032 -.282 
   Pz -.535 -.614
*
 -.275 -.530 
Late     
   Fz -.685
**
 -.747
**
 -.314 .446 
   Cz -.440 -.547 -.063 -.025 
   Pz -.221 -.405 -.104 -.102 
     
Difference/Slope     
   Fz -.041 -.039 -.286 -.154 
   Cz .049 -.025 -.056 -.169 
   Pz -.286 -.241 -.781
**
 -.846
**
 
Partial correlations controlled for age, gender, ICV, and time to scan. Time to scan computed in days from EEG 
baseline to MRI; N = 18; df = 12; * p < .05; ** p < .01. 
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Figure 3.3 Correlations between caudate and putamen shape and latency of the electrophysiological 
motor component (early CNV at Cz). Pearson’s partial correlations are shown in the left pane, raw p-values in 
the middle pane, and FDR corrected p-values in the right pane. Medial/lateral denotes viewpoint of the caudate 
or putamen presented. 
 
Figure 3.4 Correlations between caudate and putamen shape and slope of the electrophysiological motor 
component at Pz. Pearson’s partial correlations are shown in the left pane, raw p-values in the middle pane, and 
FDR corrected p-values in the right pane. Medial/lateral denotes viewpoint of the caudate or putamen presented.
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DISCUSSION 
This study examined the relationship between neural premotor processing during a 
sensorimotor integration task (CNV) and striatal morphology, to better understand the 
relationship between impaired fronto-striatal circuit mediated motor function and structural 
integrity in HD. In these findings we highlight implications for neural sources of the CNV, 
and contributions of fronto-striatal functional connectivity to premotor performance. All 
correlational analyses for volume and shape were conducted on the combined group (ALL-
HD) to increase statistical power and account for individual differences in disease 
progression.  
Volumetric analyses 
Volume associations with integrity of circuits 
CNV amplitude across scalp regions and component (early, late) showed no relationship with 
volume. However, relative activation (slope) of the CNV over parietal regions correlated with 
right and left putamen volume, with greater slope (indicating appropriate premotor 
preparation) associated with more volume in these regions. Larger putamen volumes 
(bilaterally) have been significantly associated with connectivity of M1 with non-motor 
regions, including the right precentral gyrus, and the right and left cuneus (Koenig et al., 
2014), suggesting that fronto-striatal projections to the putamen overlap across multiple, 
preferential functional network loops. Based on these results, putaminal volume, as an index 
of structural integrity, seems to be related to the ability to recruit additional compensatory 
networks. With further decreasing putaminal volumes in symp-HD, this ability may be lost; 
larger studies will be needed to confirm this hypothesis.  
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Volumetric associations with timing of premotor activation 
Timing of neural premotor activation (latency) was correlated with volume in the right 
caudate (early Fz, and Cz; late Fz), left caudate (early Cz; late Fz) and right and left putamen 
(early Fz). Additionally, motor execution variables of reaction time and speeded tapping were 
correlated with volume in the right putamen and caudate, respectively. Lower volumes in 
these regions, representing decreased structural integrity, were associated with delayed neural 
premotor activation and execution (slower overall reaction times, fewer taps in speeded trial). 
Although the groups were combined in morphological analyses, it should be noted that in our 
previous work, only symp-HD, but not pre-HD, demonstrated significantly slower reaction 
times and fewer taps during the task compared with healthy controls (Turner et al., 2015).  
Such volumetric correlations combined with normal task performance (reaction times) may 
support a threshold of maintained performance prior to significant degeneration, with 
progressive failure of fronto-striatal networks first resulting in heightened and prolonged 
premotor activation prior to the onset of performance deficits. Indeed, other studies have 
demonstrated motor performance (tapping variability) correlates with bilateral grey matter 
atrophy of caudate and putamen, white matter loss, cortical thinning (Betchel et al., 2010), 
and approach of symptom onset (Hinton et al., 2007), suggesting degeneration eventually 
impedes motor precision and possible compensation. In maintaining motor function in the 
interim, functional specificity of fronto-striatal networks and/or compensation is a complex 
process which likely varies with disease progress. For example, tapping precision in pre-HD, 
but not symp-HD, has been positively correlated with synchrony in the medial primary motor 
cortex (Poudel et al., 2014), and weakened M1 connectivity with the supplementary motor 
area and dysfunction in the dorsolateral prefrontal cortex using fMRI in pre-HD, but not 
symp-HD (Wolf et al., 2011; Wolf et al., 2012). Early structural pre-HD changes are also 
suggested to weaken M1 connectivity with premotor regions and the caudate nucleus itself 
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(Unshuld et al., 2012), which may elicit compensation, with decreased caudate and increased 
supplementary motor area and anterior cingulate activation identified in pre-HD individuals 
more than 12 years, but not less than 12 years from onset (Paulsen et al., 2004). Within the 
striatum, motor relay loops connect the M1 and the pallidum (Koenig et al., 2014) as well as 
premotor regions and the pallidum (Draganski et al., 2008) and thus may circumvent early 
atrophy.  Such temporary recruitment fallible to degeneration is consistent with clinical 
observation in HD, where by and large pre-HD individuals do not demonstrate observable 
motor impairment. This process is likely mediated by individual differences such as cognitive 
reserve (Papoutsi et al., 2014). These studies highlight the complex nature of motor 
processing in a degenerative context, with preservation of motor performance dependent 
upon functional connectivity and available resources.  
Shape analyses 
Shape associations with integrity of circuits 
Shape deflation, representing atrophy of the surface of the striatum, was most notable in 
negative correlations with CNV slope at Pz (where a flattened slope indicates unregulated 
premotor activation) corresponding to deflation to the medial and lateral aspects of the right 
(medial; central; lateral; anterior and posterior) and left putamen (medial and lateral; 
widespread). This was particularly widespread on the dorsal aspect of the putamen, with 
greater shape deflation associated with a flatter slope at Pz across the CNV period. Integrity 
of the putamen is associated with direct motoric functionality (Draganski et al., 2008), with 
dorsolateral regions responsible for motor and sensorimotor control (Alexander et al., 1986). 
Successful sensorimotor integration in the CNV requires coordination of motor and non-
motor functionality (planning and execution), with the early component of the CNV theorised 
to reflect prefrontal and SSMA; and the late component prefrontal, M1, S1, temporal, 
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occipital and SSMA activation (Hamano et al., 1997). Hence, the slope of the CNV may 
reflect more widespread connectivity of fronto-striatal circuits during premotor functions. A 
flatter Pz slope during CNV may suggest activation is inflexible and does not reflect the 
demands of the task (early and late), perhaps indicating disruption of premotor circuitry. The 
link between direct motor functionality and the putaminal integrity (as measured by shape) 
was supported by negative correlations between reaction time, Pz slope and volume of the 
right putamen. Greater atrophy was associated with slower motor execution and flatter slope, 
respectively. Atrophy to the dorsal putamen may compromise frontal motor projection areas, 
potentially reflecting a limited ability to recruit dorsolateral circuitry and regulate motoric 
function. 
Shape associations with timing of premotor activation 
Timing of activation (latency) in the early CNV was related to morphology in both medial 
(centralised) and lateral (anterior and posterior; patchy) aspects of the right caudate. Greater 
shape deflation, i.e. atrophy, in the right caudate was associated with delayed neural premotor 
activation. Structural integrity of the caudate has been associated with prefrontal motor 
control; striatal motor projections occupy the dorsolateral caudate, connecting premotor and 
M1 areas and implicating the region in motor control (Taniwaki et al., 2003; Haber, 2003). In 
pre-HD, structural changes have been associated with weakened connectivity of M1 and 
premotor regions with the caudate (Unshuld et al., 2012). In older adults, shape deflations in 
corresponding posterolateral aspects of the left caudate have previously been associated with 
motor dysfunction in age-related white matter hyperintensities (MacFarlane, et al., 2015). 
Therefore, based on our results and previous findings, degenerative changes to the (in our 
case, the right) caudate may impair motor planning and execution, resulting in irregular 
neural premotor activation and delayed motor execution.  
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In our previous paper we highlighted abnormal CNV activation in pre-HD individuals 
(Turner et al., 2015). In this follow-up paper, we aimed to clarify the contribution of the 
striatum to abnormal premotor activation. Here we demonstrate that premotor activation is 
dependent upon structural integrity of the striatum (caudate and putamen). We propose that 
disease-related atrophy progressively impedes functional connectivity of critical fronto-
striatal circuits involved in motor control, resulting in subtle premotor changes to the CNV 
profile. These consist of delayed and flattened neural premotor activation in the context of 
normal execution, and from this we draw two conclusions. First, degenerative changes to the 
right caudate morphology are associated with significantly delayed neural premotor 
activation and execution, which likely reflects impaired planning and execution of simple 
movements. Second, atrophy to the dorsolateral putamen is associated with a significantly 
flattened CNV slope at Pz. Due to circuit organisation, progressive putaminal atrophy appears 
to impede access to crucial dorsolateral circuitry used to regulate motor activation and 
additional compensatory networks which support motor performance. These results provide 
strong evidence to support the compromise of various fronto-striatal networks through 
progression of HD, as well as despecialisation during early stages of the disease to support 
motor performance. Taken together, the correlations between the CNV and morphology of 
the striatum support the utility of concurrent measurement towards localising neural premotor 
pathways and developing complimentary biomarkers in HD which can potentially be 
implemented in clinical assessment and prognostication. 
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SUPPLEMENTARY MATERIALS 
Table 3.3 Partial correlations between caudate and putamen volume and amplitude, relative amplitude 
(slope) and latency of electrophysiological motor component by disease status.  
Partial correlations controlled for age, gender, ICV, and time to scan. Time to scan computed in days from EEG 
baseline to MRI; N = 18; df = 12; * p < .05; ** p < .01. 
 
 
 Pre-HD (n = 12) Symp-HD (n = 6) 
 Caudate Putamen Caudate Putamen 
 Right Left Right Left Right Left Right Left 
Amplitude         
Early         
   Fz  -.181 -.378 -.115 -.266 -.862 -.980 -.137 .932 
   Cz  -.114 -.259 .008 -.057 -.769 -.935 .026 .978 
   Pz  .419 .345 .113 .235 -.534 -.779 .333 .994 
Late         
   Fz  -.084 .004 -.424 -.428 -.872 -.984 -.156 .925 
   Cz  -.577 -.673 .199 -.138 -.439 -.707 .433 .977 
   Pz  .332 .376 -.167 -.088 -.319 -.610 .545 .942 
         
Latency         
Early         
   Fz -.619 -.298 -.637 -.694 .726 .910 -.090 -.989 
   Cz -.836
**
 -.728
*
 .0802 -.206 -.960 -.818 -.814 .376 
   Pz -.617 -.701 -.352 -.596 -.874 -.669 -.923 .160 
Late         
   Fz -.458 -.642 .0245 -.310 -.422 -.694 .450 .973 
   Cz .076 -.260 .589 .412 -.184 -.493 .658 .885 
   Pz .236 -.129 .327 .277 .215 -.113 .900 .632 
         
Slope         
   Fz -.049 .0228 -.375 -.364 -.937 -.772 -.855 .306 
   Cz -.456 -.417 -.614 -.796
*
 -.189 -.497 .654 .887 
   Pz -.233 -.058 -.914
**
 -.893
**
 .837 .615 .948 -.0903 
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CHAPTER 4 – STUDY THREE 
CORPUS CALLOSUM THICKNESS AND ASSOCIATIONS WITH 
ELECTROPHYSIOLOGICAL PREMOTOR PROCESSING IN 
HUNTINGTON’S DISEASE 
Does electrophysiological premotor dysfunction relate to integrity of 
the corpus callosum? 
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ABSTRACT 
Background: Functional motor connectivity is dependent upon multiple inter-hemispheric 
networks. The corpus callosum acts as the major grey matter transverse commissure 
connecting critical grey matter tracts between cortices, and connects crucial fronto-striatal 
circuitry. Huntington’s disease (HD) progressively compromises the structural integrity of the 
corpus callosum, causing motor dysfunction. We evaluated associations between thickness of 
thecorpus callosum and neural premotor processing (Contingent Negative Variation; CNV), 
with aim of investigating localisation and preservation of motor function in HD. 
Methods: Magnetic resonance imaging (MRI) scans and electrophysiological (EEG) 
measures of premotor processing were obtained from a combined HD group (12 
presymptomatic; 7 symptomatic). Mean cortical thickness was measured across anatomical 
connections, comprising the frontal, parietal, temporal and occipital lobes, and the cingulate. 
The CNV was measured at early and late timepoints, and separated by region (Fz, Cz, Pz), 
with amplitude, latency, and relative amplitude (difference between early/late) included. 
Correlational analyses (thickness) included covariates of age, gender, interacranial volume, 
and time between EEG and MRI. 
Results: No correlations with premotor variables survived FDR corrections. However, a 
number of premotor variables showed promising associations. Thickness of mid-posterior 
(motor) regions was positively associated with early amplitude at Cz (greater amplitude, 
thicker corpus callosum), and negatively associated with Fz slope (steeper slope with thinner 
corpus callosum). Thickness of mid-anterior regions (frontal cortex/premotor and 
supplementary motor areas) was negatively correlated with early amplitude at Cz, late 
amplitude at Fz, Cz and Pz, relative amplitude at Fz, and Cz slope (thinner corpus callosum 
with greater amplitude and steeper slope). 
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Conclusions: While premotor associations did not survive FDR, findings follow the pattern 
of known anatomical connections. Integrity of the corpus callosum at critical junctions such 
as mid-posterior regions may determine strength (amplitude) and stability (slope) of the 
premotor potential across time. Atrophy of the corpus callosum could determine functionality 
of inter-hempispheric circuits, as well as access to ancillary networks.  
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INTRODUCTION 
Huntington’s disease (HD), a trinucleotide repeat disease, causes widespread atrophy to 
cortical grey and white matter (Vonsattel et al., 1985). Concurrent, localised degeneration 
progressively disrupts motor regions and connections within the cortex. Symptomatic (symp-
HD) individuals present with impairment to both voluntary and involuntary movement (e.g. 
Nance, Paulsen, Rosenblatt, & Wheelock, 2012; Smith, Brandt, & Shadmehr, 2000). 
However, characteristic atrophy begins up to 20 years prior to clinical onset (e.g. Aylward et 
al., 2012; Domínguez et al., 2013; Georgiou-Karistianis et al., 2013; Tabrizi et al., 2009; 
Tabrizi et al., 2011; Tabrizi et al., 2013; van den Bogaard et al., 2011a.b) in presymptomatic 
(pre-HD) individuals with intact motor function, suggesting progressive deterioration of 
motor connectivity. Recently, we demonstrated abnormal premotor electrical activity in pre-
HD during a sensorimotor integration task using EEG, in the context of normal motor 
execution (reaction time; Turner et al., 2015). In a follow-up study, latency and degree of 
activation during premotor processing was correlated with morphology (shape and volume 
quantitative measures of structural integrity) of the caudate nucleus and putamina in the 
striatum in a combined HD sample (Turner et al., 2016, in review). The striatum has afferents 
from premotor, motor, and dorsolateral prefrontal cortex, primary and secondary inter-
hemispheric circuits used in motor control (Alexander et al., 1986; Draganski, 2008). As 
functional motor connectivity appears dependent upon the structural integrity of such 
circuitry traversing hemispheres, it is highly likely that neuroanatomical commissures such as 
the corpus callosum are crucial to premotor functionality.  
The corpus callosum is a major transverse commissure which interconnects cortical grey 
matter tracts. These tracts consist of homotopic (e.g. right and left frontal lobe; Rosenbloom 
& Pfefferbaum, 2008), as well as heterotopic interconnections (e.g. frontal to parietal lobe; 
Iacobini & Zaidel, 2004). The corpus callosum is topographically organised, with anterior 
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portions linking the fronto-parietal cortex (Chao et al., 2009). The most anterior corpus 
callosum contains fibre clusters connecting premotor and supplementary motor regions 
(passing through anterior and posterior midbody), and anterior midbody connecting the 
primary motor cortex (passing through posterior midbody and isthmus). However, much less 
is known about heterotopic regions. 
The corpus callosum provides inter-hemispheric connections to cortical and subcortical areas 
vulnerable in HD, and is a known anatomical marker of neuropathology; loss of thickness 
and microstructural changes commencing in pre-HD have been identified using magnetic 
resonance imaging (MRI) and Diffusion Tensor Imaging (DTI) methods (e.g. Crawford et al., 
2013; Di Paola et al., 2012; Dumas et al., 2012; Klöppel et al., 2008; Phillips et al., 2013; 
Rosas et al., 2006; Rosas et al., 2010). Thickness of the corpus callosum has been associated 
with CAG repeat length and disease burden scores, as well as clinical motor and cognitive 
measures of dysfunction, which are traditionally used as measures of disease progression 
(Bohanna et al., 2011; Di Paola et al., 2012; Dumas et al., 2012; Klöppel et al., 2008; Phillips 
et al., 2013; Rosas et al., 2006). Corpus callosum atrophy is found in other neurodegenerative 
diseases, including Alzheimer’s disease, where it is associated with cognitive decline (Zhu et 
al., 2014), as well as with general abnormalities in cortical grey matter (Tekgul et al., 1999). 
Atrophy may reflect early demyelination (Di Paola et al., 2012; Phillips et al., 2013), 
occurring prior to clinical onset and compromising pyramidal and extrapyramidal pathways 
crucial to cortical connectivity and premotor function.  
Contingent Negative Variation (CNV) is a functional electrophysiological measure of 
sensorimotor integration and premotor planning (Ikeda et al., 1997), involving cortical 
sources including the supplementary motor area, primary motor area (M1), primary sensory, 
prefrontal and supplementary sensorimotor area (SSMA), as well as temporal and occipital 
areas (Macar, Anton, Bonnet & Vidal, 2004; Rektor et al., 2004; Hamano et al., 1997). In our 
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previous study, aberrant premotor activation in the CNV was suggested to reflect abnormal 
hemispheric interactions, including damage to striatum and associated motor, premotor, and 
dorsolateral prefrontal cortex circuit loops (Turner et al., 2016, in review). The corpus 
callosum is the largest white matter tract, and contains over 200 million white matter fibres 
which transfer information between the left and right cortical hemispheres (Aboitiz & 
Montiel, 2003). However, only a small number of these white matter fibres in the corpus 
callosum are innervated by fronto-striatal circuits (Phillips et al., 2013), suggesting 
abnormalities in the corpus callosum may provide distinct and complimentary insight into 
functional connectivity. Investigating correlations between neuroanatomical biomarkers and 
premotor dysfunction could help to create an ensemble measure, thereby increasing 
specificity in assessing disease progression. 
To our knowledge, this is the first study to relate thickness of the corpus callosum to 
electrophysiological premotor performance in HD. We hypothesised that functional electrical 
premotor activity would correlate with thickness profile of the corpus callosum as a measure 
of circuit structural integrity in mid-sagittal regions connecting/interacting with motor regions 
of the cortex. Specifically, we expected correlations with thickness of first and mid-anterior 
regions, reflecting connections to the premotor, supplementary, and primary motor regions. 
 
METHODS 
Acquisition Procedures 
Participants 
Participant data was obtained at two time points in 2008-2009 as part of the IMAGE-HD 
project (Georgiou-Karistianis et al., 2013). Participants were 7 HD individuals (5 males; 
symp-HD), and 12 prodromal individuals with no clinical manifestations (7 males; pre-HD), 
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who participated in both studies. Following our previous protocol (Turner et al., 2016, in 
review), both HD samples were combined as one group for all analyses (ALL-HD), to better 
account for inter-individual differences in disease progression, and to improve sample size 
and statistical power.  
All participants provided consent to participate in EEG and imaging studies and were 
assessed by a neurologist (A.C.). At time of EEG, all participants completed a neurocognitive 
assessment battery consisting of a speeded tapping task (Hinton et al., 2007), the Trails B task 
to assess executive functioning (Tombaugh, 2004), the Hopkins Verbal Learning Task 
(HVLT) to assess memory functioning (Brandt, 1991), and the Beck Depression Inventory-II 
to assess depressive symptoms (BDI-II) (Beck, Steer, & Brown, 1996). The time period 
between EEG testing and MRI was computed for each individual (‘Time to Scan’), and used 
as a covariate in all imaging analyses. Ethics approval was obtained from the Melbourne 
Health Human Research Ethics Committee and for image analysis, the ANU Human 
Research Ethics Committee. Research procedures complied with the Code of Ethics of the 
World Medical Association (Declaration of Helsinki). 
Contingent Negative Variation (CNV) Task 
A Go/No-Go Task was employed to elicit electrophysiological components of sensorimotor 
integration (CNV). All participants were right handed and elected to use their dominant hand 
during the motor task. A 500 ms warning stimuli was presented (blue light flash; S1), 
followed 2.5 s later by an ‘X’ or ‘Y’ visual cue (S2), appearing randomly on either the right 
or left side of the screen. Participants were instructed to respond only to the ‘X’ stimulus and 
to press a button corresponding to its position on the screen. The No-Go stimuli occurred in 
20% of trials, and the inter-trial interval was randomly varied between 2500 and 4000 ms 
across a total of 90 trials. 
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Imaging 
Structural MRI images were acquired using a Siemens Magnetom Tim Trio 3 Tesla scanner 
(Siemens AG, Erlangen, Germany), with a 32-channel head coil at the Murdoch Children’s 
Research Institute (Royal Children’s Hospital, Victoria, Australia). High resolution T1 
weighted images were taken for each participant (192 slices, 0.9 mm slice thickness, 0.8 mm 
in-plane resolution, TE = 2.59 ms, TR = 1,900 ms, flip angle = 9°). 
Data Analysis 
Electrophysiological data 
The continuous EEG was corrected for ocular and EMG artefacts. Semi-automated 
processing was used to sweep for ocular and muscle movements and determine rejections 
(±150µV; excluding EOG channels). EOG corrections were made using a validated protocol 
described elsewhere (Croft & Barry, 2000). All data was visually inspected for remaining 
artefacts, with subsequent rejection of contaminated trials.  
The CNV was filtered using a 0.03 to 35 Hz bandpass zero phase shift filter (24 dB roll-off), 
consistent with previous studies (de Tommaso et al., 2007, Turner et al., 2015). Selection of 
electrode sites was made a priori, and aimed to mirror both our previous study (Turner et al., 
2015), as well as prior studies suggesting possible abnormal activation across these sites 
(Bartenstein et al., 1997; Feigin et al., 2005; Gavazzi et al., 2007; Ikeda et al., 1997; Klöppel 
et al., 2009; Weeks, Ceballos-Baumann & Piccini, 1997). EEG data was epoched to the 
period of -3500 to 1000 ms respective to S2 (Go-No-Go) cue presentation.  Epochs were 
baseline corrected (relative to -3500 to -3000 ms) and averaged separately for each electrode 
site (Fz, Cz, Pz). Both Go and No-Go trials were included in the grand average. Amplitudes 
of early CNV (eCNV) were measured as maximum amplitude obtained in the period 550-750 
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ms following the presentation of S1, late CNV (lCNV) as maximum amplitude occurring in 
the 200 ms prior to the onset of S2 (de Tommaso et al., 2007). The relative amplitude of the 
CNV was computed using peak-to-peak values comprised of the difference between the peak 
during the early CNV (the period -2450 to -2250 ms) and that of the late CNV (the period -
200 to 0 ms). These values were obtained using MATLAB
™ 
for each participant, on each 
electrode site (Fz, Cz, Pz) 
CC Thickness 
Measurement of corpus callosum morphometry was obtained using a method described 
previously (Adamson et al., 2014; Adamson et al., 2011). Figure 4.1 depicts the method we 
used to measure morphometry of the corpus callosum (Adamson et al., 2014; Adamson et al., 
2011). First, the white matter was identified from the MRI. Then the algorithm delineatated 
the upper (green) and lower edges of the structure (blue). After this, 100 equidistant 
segmentations (red) are calculated between the upper and lower edge of each participant’s 
corpus callosum. The length of those 100 segmentations (millimeters) was graphed as a 
function of the node (i.e. the x-axis shows the 100 equidistant points along the entire length 
of the mid-sagittal region, and the y-axis shows the length (mm) of the 100 red 
segmentations). This allows us to describe the shape of the corpus callosum numerically, in 
terms of the length (or thickness) of these segmentations. 
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Figure 4.1 Measurement of corpus callosum morphometry. Reproduced with permission from Adamson et al., 2011. Top:  Delineation method showing measurement of 
100 equidistant segments (red) vertically between upper (green) and lower (blue) boundary of mid-sagittal region in one subject. Bottom: Segment thickness (length of red 
lines) profile for the same subject (100 segments are represented on the x-axis (red lines in A), corresponding segment thickness represented on the y-axis). 
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Statistical analyses 
For each electrophysiological variable (latency, amplitude slope) across the CNV (early, 
late), we tested the association with mean cortical thickness of the corpus callosum using a 
Pearson R correlation. All analyses included intracranial volume (ICV), age, and time to MRI 
via regression as residuals. Correction for multiple comparisons was performed with a false 
discovery rate (FDR) at the standard 5%. 
 
RESULTS 
Demographic and clinical variables 
Participant demographics and clinical data are displayed in Table 4.1. Non-parametric Mann-
Whitney U tests indicated that the symp-HD group were significantly older (p = .045). Symp-
HD performed significantly more poorly on Trails B (p = .005; 158.00 ms and 73.96 ms) 
speeded finger tapping (p < .001; 335.53 and 215.86) and the Unified Huntington’s Disease 
Rating Scale Total Motor Score (TMS; p < .001). 
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Table 4.1 Demographic data between groups.  
Mean ± SD 
 Pre-HD (n = 12) Symp-HD (n = 7) ALL-HD (n = 19) 
Demographics    
Gender (M:F) 7:5 5:2 12:7 
Age 42.16 ± 12.14 (24, 
64) 
51.57 ± 8.56 (41, 
65)
*
 
46.58 ± 12.25 
Education (yrs) 11.83 ± 2.28 11.57 ± 2.63 11.73 ± 2.35 
CAG  42.16 ± 2.72 42.57 ± 1.51 42.31 ± 2.31 
ICV  1425.24 ± 170.82 1429.82 ± 120.14 1426 ± 150.50 
Time to Scan -40.33 ± 108.73  
(-242, 105) 
-276.28 ± 70.70  
(-364, -174)
*
 
-127.26 ± 150.22 
(-364, 105) 
Probability of 
Diagnosis  
0.21 ± 0.23 - - 
Illness Duration - 1.42 ± 0.78 - 
DBS 269.00 ± 104.42 408.92 ± 142.04
**
 320.55 ± 134.90 
UHDRS (TMS) 0.33 ± 0.65 (0, 2) 17.42 ± 8.32 (11, 33) 6.63 ± 9.75 
IQ Estimate 112.90 ± 5.48 110.82 ± 7.00 112.13 ± 5.98 
BDI-II 6.75 ± 7.60 3.85 ± 3.57 5.68 ± 6.45 
Trails B 73.96 ± 23.63 158.00 ± 94.01
**
 104.92 ± 70.86 
Speeded Tapping 215.86 ± 12.65 335.53 ± 100.04
**
 259.96 ± 83.37 
HVLT Total Recall 24.91 ± 4.29 18.71 ± 9.12 22.63 ± 6.96 
HVLT Delayed 
Recall 
8.75 ± 1.91 7.28 ± 3.63 8.21 ± 23.25 
HVLT % Retention 87.45 ± 10.46 88.72 ± 37.67 87.92 ± 23.25 
HVLT Recognition 
Discrimination Index 
10.25 ± 1.21 9.00 ± 2.70 9.79 ± 1.93 
Volume (mm
3
)    
Right Putamen 2692.88 ± 505.79 1673.83 ± 226.60
**
 2317.44 ± 654.61 
Left Putamen 2682.02 ± 579.64 1703.18 ± 192.96
**
 2321.40 ± 673.10 
Right Caudate 3265.68 ± 662.22 2180.11 ± 199.59
**
 2865.74 ± 755.45 
Left Caudate 3208.72 ± 711.01 2115.84 ± 156.22
**
 2806.08 ± 781.30 
CAG, cytosine-adenine-guanine; ICV: Intracranial volume; IQ (NART: National Adult Reading Test 2
nd
 
Edition); time to scan computed in days from EEG baseline to MRI; probability of onset in 5 years calculated 
from Langbehn et al (2004); Disease Burden Score (CAG-35.5)*age; UHDRS, Unified Huntington’s Disease 
Rating Scale (pre-HD, UHDRS <5; symp-HD, UHDRS ≥5); TMS, total motor score of the UHDRS; predicted 
Full Scale IQ converted from performance on the National Adult Reading Scale. Non-parametric Whitney Mann 
U tests for differences between groups, * p < .05, ** p < .01.  
 
Correlations with thickness – significant results surviving FDR 
As shown in Figure 4.2, mid-sagittal thickness in mid to posterior regions was significantly 
associated with HVLT recognition and total scores. That is, the mid to posterior region was 
significantly thinner with greater HVLT recognition and total scores. 
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Figure 4.2 Profile correlations with Hopkins Verbal Learning Test Recognition and Total subscores. FDR 
corrected Pearson’s R correlations for the combined sample (ALL-HD) are displayed. Covariates of age, sex, 
intracranial volume and time between EEG-MRI were included in analyses. 
 
Correlations with thickness – significant results not surviving FDR 
Figures 4.3 and 4.4 display raw significant correlations with the corpus callosum and motor 
variables which did not survive FDR correction; please note these results refer to raw 
significance only. For amplitude measures, early amplitude at Cz was positively correlated 
with thickness in mid-posterior regions (motor), and negatively correlated with anterior 
regions (frontal cortex); greater amplitude is associated with greater thickness in mid-
posterior regions, and thinner in anterior regions. Late amplitude of the CNV at Fz, Cz, and 
Pz were negatively correlated with thickness in mid-anterior regions (frontal cortex/ premotor 
and supplementary motor areas), with greater amplitude associated with smaller, i.e. thinner, 
corpus callosum. This was most pronounced at Cz. Relative amplitude at Fz (early/late 
difference) was negatively correlated with anterior thickness (frontal cortex), with greater 
relative amplitude associated with thinner corpus callosum. 
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CNV slope at Fz was negatively correlated with thickness of the corpus callosum in mid-
posterior regions (primary motor cortex), and slope at Cz was negatively associated with 
thickness in posterior (parietal) and mid-anterior regions (frontal cortex/premotor and 
supplementary motor areas). At both Fz and Cz, greater slope values were associated with 
thinner regions. Late latency of the CNV was positively correlated with mid-posterior 
thickness (parietal/primary sensory cortex); delayed latency of the potential was associated 
with greater thickness in this region. 
 
 
Figure 4.3 Profile correlations with electrophysiological motor measures (amplitude). FDR corrected 
Pearson’s R correlations for the combined sample (ALL-HD) are displayed. Covariates of age, sex, intracranial 
volume and time between EEG-MRI were included in analyses. 
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Figure 4.4 Profile correlations with electrophysiological motor measures (slope/latency/relative 
amplitude). FDR corrected Pearson’s R correlations for the combined sample (ALL-HD) are displayed. 
Covariates of age, sex, intracranial volume and time between EEG-MRI were included in analyses. 
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DISCUSSION 
This study utilised a combined sample of 19 gene-positive HD individuals (12 
presymptomatic and 7 symptomatic) and aimed to investigate the relationship between 
cortical grey matter thickness in the corpus callosum and premotor electrical activity. Using a 
robust, fully automated method, we show unexpected associations between thickness and 
executive functioning. Though we identified significant associations between thickness and 
premotor activity, these did not survive FDR corrections (type II error). However, these 
associations follow a pattern of known anatomical connections (Rosenbloom & Pfefferbaum, 
2008). Thus, we aim to explore the raw, uncorrected analysis as an insight to possible 
assocations between integrity of the corpus callosum and electrophysiological measures to 
provide insight for further studies. 
Results surviving FDR 
Cortical grey matter thickness was significantly correlated with HVLT recognition and 
overall scores. Thinner corpus callosum in mid to posterior regions, reflecting reduced 
structural integrity, was associated with higher (better) scores in HVLT recognition. The mid-
posterior regions feature connections to the primary sensory cortex and primary motor cortex 
(Chao et al., 2009). Greater atrophy to mid posterior regions may neccessitate recruitment of 
additional circuitry to aid in completing executive tasks, paradoxically enhancing individual 
task performance. 
Premotor associations not surviving FDR 
In premotor variables, amplitude of the early (Cz), late (Fz, Cz, Pz), slope (Cz), and relative 
(early/late difference, Fz) CNV were significantly correlated with corpus callosum thickness 
in anterior and mid-anterior regions. Greater amplitudes/steeper slopes were associated with 
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thinner regions, which feature homotopic regional cortico-cortical connections to the frontal 
cortex, and heterotopic connections to the premotor and supplementary motor areas (Chao et 
al., 2009). During the CNV, early activation has been theorised to reflect prefrontal and 
supplementary sensory motor activation (Hamano et al., 1997). The frontal cortex provides 
complex integration and regulation of sensory, memory, executive, and language 
functionality. Within its cortico-striatal networks, fronto-circuitry such as the dorsolateral 
prefrontal and premotor and motor circuits provide motor connectivity with anatomical 
plugins to the caudate and putamen (Draganski et al., 2008; Alexander et al., 1986). 
Previously, we suggested that CNV slope might reflect connectivity issues of fronto-striatal 
circuitry (Turner et al., 2016, in review). Here, loss of structural integrity of the corpus 
callosum could represent more widespread connectivity issues in crucial homotopic and 
heterotopic circuitry relating to DLPFC and premotor circuits, resulting in unregulated 
premotor activation. 
Measures of early amplitude (Cz) and slope (Fz) of the CNV were significantly correlated 
with thickness of the corpus callosum in mid-posterior regions. Greater amplitude and flatter 
slope were associated with thicker regions corresponding to the primary motor cortex (Chao 
et al., 2009). As an electrode site, Cz roughly corresponds to motor regions, and therefore this 
correlation is unsurprising. A flatter slope at Fz may suggest activation is consistent across 
task (early and late), which may support the hypothesis that better regulation of premotor 
activation at Fz is dependent on structural integrity of the corpus callosum. In addition, we 
identify that steeper slope at Cz is correlated with thinner mid-posterior regions; these 
correspond to parietal regions, suggesting compromised integrity of the corpus callosum 
deregulates motor functionality at the motor cortex itself. These findings are intriguing: in our 
previous studies, correlations with CNV slope and putamen volume have been restricted to 
parietal (Pz) regions. Parietal over-activation has previously been identified in a context of 
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impaired striatal connectivity (and reduced frontal activation; Bartenstein et al., 1997), 
suggesting that that fronto-parietal pathways may provide ancillary support as primary 
(fronto-striatal) networks fail with atrophy. 
Latency (Fz) of the late CNV was significantly correlated with mid-posterior thickness of the 
corpus callosum. Delayed onset of the potential at Fz was associated with thicker regions 
corresponding to the parietal cortex and primary sensory cortex. This may support our 
previous observation that preserved integrity of the corpus callosum in HD maintains frontal 
functions which provide ancillary support for weakened motor connectivity. In terms of 
frontal premotor activation, with greater structural integrity, individuals are able to initiate 
and regulate premotor activation later with no performance impediment.  
Limitations 
Statistical analysis of thickness involved stringent corrections for type II error (FDR) 
conducted within a small sample size (N = 19), which combined both gene-positive groups 
(pre-HD and symp-HD).  Although we utilised a combined sample to increase statistical 
power, we also feel that combining presymptomatic and symptomatic individuals can better 
account for inter-individual variation in what is clearly a dimensional process of atrophy. 
However, low power reduces our ability to detect smaller underlying effects. Our premotor 
associations with thickness of the corpus callosum did not survive FDR corrections, but they 
do follow known (and anticipated) homotopic anatomical connections between motor and 
premotor regions (Alexander et al., 1986; Chao et al., 2009; Draganski et al., 2008). The 
associations may not be robust to FDR corrections due to inter-individual variation in 
thickness and disease progression. While intriguing, it is difficult to comment upon 
heterotopic connectivity in the corpus callosum as they are less well mapped than homotopic 
connections (Chao et al., 2009). The inter-individual variation is particularly important given 
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we combined presymptomatic and symptomatic individuals within one group. These factors, 
combined with a small sample size, may have resulted in our failure to reject a false null 
hypothesis. 
Conclusions 
This study has provided evidence of correlations between cortical grey matter thickness and 
executive functioning measures in HD. Additionally, we provide exploratory raw correlations 
of thickness of the corpus callosum with premotor activation, as measured via the 
electrophysiological measure CNV, and regions with homotopic regional cortico-cortical 
connections to frontal, premotor, motor, and parietal regions. This provides preliminary 
indications that structural integrity of the corpus callosum may determine integrity and 
regulation of motor function, and that atrophy could contribute to motor dysfunction in 
symptomatic stages of the disease. This work extends our previous work demonstrating 
correlations between shape deflation in the putamen and caudate and electrophysiological 
premotor activity (Turner et al., 2016, in review), and provides further exploratory insights 
into motor coordination and maintenance through inter-hemispheric networks in HD. Future 
directions would involve incorporating larger sample sizes of pre-HD, HD and controls with 
functional electrophysiology measures and investigating correlation with thickness as a 
measure of structural integrity of the corpus callosum. Additional, measures such as diffusion 
tensor imaging (DTI) combined with white matter tractography and cortical morphometry 
could aid in identifying compensatory (robust) and vulnerable circuits. This would enhance 
our understanding of motor localisation and compensation, as well as provide a target to trial 
interventions to maintain circuit functionality and improve connectivity through brain 
stimulation techniques such as transcranial magnetic stimulation (TMS; Lefaucheur et al., 
2014).  
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CHAPTER 5 – DISCUSSION 
Summary of individual studies, overall conclusions and future 
directions. 
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DISCUSSION 
5.1 Summary of Aims and Hypotheses  
5.1.1 Chapter 2: Electrophysiological Premotor Activation in Huntington’s Disease 
In HD literature, neurodegeneration up to 20 years prior to symptom onset (Aylward et al., 
2012; Domínguez et al., 2013; Georgiou-Karistanis et al., 2013a; Paulsen, 2010; Tabrizi et 
al., 2009; Tabrizi et al., 2011; Tabrizi et al., 2013; van den Boggard et al., 2011a, b), has been 
well-established, and damages key regions involved in functional fronto-striatal and inter-
hemispheric motor connectivity (Alexander et al., 1986; Chao et al., 2009; Draganski et al., 
2008; Jahanshai et al., 2015). Hence, there were two key questions motivating the initial 
study. First, why do persons with pre-HD show minimal differences from healthy controls in 
functional motor tasks assessed to date? An answer to the first question raises two, not 
incompatible, possibilities; 1) current motor tasks are not sensitive enough to detect early 
dysfunction of fronto-striatal and inter-hemispheric dysfunction to circuitry, and/or 2) motor 
performance is maintained (in the form of normal reaction times and task execution) in early 
stages of HD, in spite of significant compromise to circuitry, through unknown neural 
mechanisms.  
This leads to the second key question: how is this motor function preserved, and where does 
it begin to fail? One previous task that has identified differences in motor function in HD has 
been in variability between taps during finger tapping, a simple paradigm in which 
differences were detected between persons with pre-HD and controls in more subtle measures 
(inter-tap variability); neuroanatomically, these measures correlated with structure (grey 
matter atrophy of caudate and putamen, white matter loss, general cortical thinning; Betchel 
et al., 2010), with greater volume yielding lower variability. Overall, this suggests motor 
control is eventually impeded by degeneration, and may begin with subtle changes such as in 
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precision of simple movements. A major limitation of prior findings is that they lack 
sensitivity, as they relate to a single task, and thus may have limited utility when used in 
tracking individual disease progression. Therefore, it is critical to identify other tasks that 
could reliably quantify cerebral changes in functional motor connectivity across the disease. 
We hypothesised that finger tapping, paired with motor-response-potentials (MRPs) collected 
through EEG, would improve task sensitivity and provide a means of accessing subtle 
components of motor processing, such as motor efficiency and consistency, as well as early 
stages of motor planning prior to the initiation of movement. Such sub-clinical differences in 
neuronal (ensemble) processing could correspond to structural atrophy and dysfunction of 
neurocircuitry, and provide insight into integrity and functional connectivity to the primary 
motor cortex (M1) and supplementary motor areas, as well as crucial subcortical structures. 
From a structural neurocircuit basis, we reasoned that atrophic disruption of connectivity 
might show its hand in changes to the integrity and efficiency of the electrophysiological 
motor response, rather than in task execution itself. 
Despite their potential utility, there is a scarcity of research examining motor potentials in 
Huntington’s disease. If MRPs provide insight into the integrity of the motor response 
(internal factors contributing to performance, rather than a discrete outcome such as reaction 
time), then this represents an area in which fronto-striatal and inter-hemispheric dysfunction 
become evident. Of the available studies, two have examined the Readiness Potential (RP), 
finding no differences between presymptomatic individuals and controls, and reduced peak 
amplitude and slope components in symp-HD compared with healthy controls. To date, only 
one study has examined the Contingent Negative Variation (CNV), and only in a symp-HD. 
These two tasks tap into different potentials (premotor preparation and motor execution), and 
show differences in Parkinson’s individuals (Ikeda et al., 1997), with more significant deficits 
observed in the CNV rather than the RP. Thus, this First Study aimed to investigate the RP 
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and CNV in Huntington’s disease to investigate resource allocation (amplitude), timing 
(latency), and consistency (relative amplitude/slope) of premotor and motor responses 
(Figure 5.1). A simple finger tapping task was used to elicit these potentials to minimise 
excessive activation during the task.  
 
 
Figure 5.1 Schematic diagram illustrating thesis structure. 
 
Study One identified abnormal neural premotor activation occurring prior to movement 
(pressing a button) in presymptomatic individuals in a context of normal performance 
(reaction time) and execution potentials (the RP). We showed that pre-HD individuals begin 
preparing earlier for movements, and displayed increased activation for longer across the 
period, prior to actual initiation of movement. Despite prolonged activation, pre-HD 
individuals did not differ from controls in the extent (amplitude) of premotor and motor 
activation, nor in their execution (reaction times, RP), suggesting that premotor relative 
activation represents a subtle measure of circuit dysfunction which occurs in spite of 
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considerable inter-individual variation in activation which would be otherwise undetected in 
regular motor tasks. Relative premotor activation at Cz reliably differentiated pre-HD 
individuals from controls; this was an exciting finding of functional difference in early stages 
of the disease. Hyperactivation could represent the brain attempting to compensate for early 
connectivity changes in pre-HD, and/or an inability to regulate the motor response itself. This 
is consistent with other studies in pre-HD which suggest a progressive breakdown of 
connectivity with M1 between the supplementary motor area and dorsolateral prefrontal 
cortex (Wolf et al., 2010; Wolf et al., 2011), and the caudate (Unshuld et al., 2012), as well as 
compensatory activation of the supplementary motor area and anterior cingulate instead of 
the caudate in those more than, but not less than 12 years from onset (Paulsen et al., 2004). 
When paired with results showing positive correlations between tapping precision and medial 
M1 synchrony in pre-HD, but not symp-HD, this implies a dynamic reorganisation of motor 
circuitry to support function in the context of early atrophy. This reorganisation likely fails as 
atrophy progresses; symp-HD demonstrated significantly slower reaction times, although 
with no detriment to response inhibition accuracy during the task.  Breakdown of response 
inhibition has previously been found in symp-HD and pre-HD (Beste et al., 2008; Beste et al., 
2011); if response inhibition is intact, but reaction time impaired, compensation costs of 
maintaining accuracy are likely reflected in the inefficient processing of the RP as seen in our 
study. 
 
5.1.2 Chapter 3: Striatal Structural Integrity and Functional Motor Response Integrity 
If motor dysfunction in pre-HD begins as an inability to regulate the premotor response, the 
question of the contribution of motor circuitry to premotor activation emerges. Following on 
from Study One, Study Two aimed to investigate the relationship between motor localisation 
and functional connectivity in the premotor responses. Despite considerable time since 
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identifying the genetic marker for HD (The Huntington’s Disease Collaborative Research 
Group, 1993), there is a limited understanding of underlying neural mechanisms and/or the 
progressive changes to functional connectivity during the course of the disease. In Study Two 
study, we provided important evidence linking integrity of the premotor response to 
morphology of the striatum. This study was designed to investigate whether the premotor 
response was in part, determined by functional connectivity of fronto-striatal motor circuitry. 
Koenig et al (2014) identified that both short and long range disturbances in functional 
connectivity with M1 were accompanied by striatal volume loss. As the striatum represent 
critical anatomical landmarks in motor connectivity, structural integrity of the caudate and 
putamen was hypothesised to determine functional connectivity (Figure 5.2).  
 
 
Figure 5.2 Schematic diagram illustrating thesis structure. 
 
Study Two identified that the time of pre-movement activation (when individuals begin 
preparing for a movement) was dependent upon structural integrity, and correlated with 
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morphology of the caudate and putamen. Specifically, we found that latency of the early 
CNV at Fz and Cz were associated with associated with volume loss to the right caudate, 
with Cz also associated with left caudate loss, and the latency of the late CNV was 
significantly positively associated with right and left caudate volume. In these associations, 
greater volume predicted faster onset of the CNV peak. In terms of shape deflation, latency of 
the early CNV at Cz was significantly associated with greater shape deflation in medial and 
lateral aspects of the right caudate, areas that connect to premotor and motor fronto-striatal 
circuits. Greater atrophy was associated with slower onset of the early CNV peak centro-
parietally, and the late CNV peak frontally. This suggests that primary motor circuits fail with 
initial degeneration and are compensated for (prior to more significant degeneration) by 
indirect motor supports, such as the DLPFC and subcortical structures of the superior 
colliculus, pendunculopontine nucleus, periaqueductal grey, pontine nuclei and medullary 
reticular formation (Erro, Lanciego & Gimenez-Amaya, 1999; Krout & Loewy, 2000; Krout, 
Loewy, Westby & Redgrave, 2001). 
Shape deflation in both the right and left putamen were significantly associated with CNV 
parietal slope. Individuals with less volume and greater surface deflation (i.e. atrophy) to 
these regions could not prepare as early for the task (latency) and had greater variability in 
activation across the premotor period (slope). This was unsurprising; the putamen, 
particularly dorsolaterally, is a critical region in motor control (Alexander et al., 1990), with 
fronto-striatal projections overlapping in parallel and converging preferential loops that, in 
addition to afferents to M1, may be responsible for recruitment of additional neural resources 
to support performance.  
Thus Study Two, in part, supported the hypotheses that within a combined sample, increased 
premotor activation (as measured by CNV amplitude) would be associated with smaller 
volumes in the caudate and putamen and greater shape deflation (atrophy) in the lateral 
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posterior caudate and putamen. Overall, it was concluded that the CNV is a sensitive measure 
of premotor activation, as both timing (latency) and consistency (slope) was significantly 
related to structural integrity of the striatum. This was found in both regional volumetric and 
deflation changes to the caudate and putamen, and is found after stringently controlling for 
age, sex, ICV and time since MRI (from EEG) in a small (N = 18), combined HD sample. 
These findings highlight the importance of the striatum in functional connectivity of motor 
circuitry, and suggest that motor sequalea may emerge through a progressive breakdown of 
fronto-striatal circuitry when atrophy can no longer be ameliorated. A breakdown in circuitry 
may occur due to grey matter atrophy (compromising coexisting cell bodies and processes 
within structures such as the striatum), however, white matter atrophy (destabilising 
myelinated fibres and axons) likely plays a role (Phillips et al., 2013).  
 
5.1.3 Chapter 4: Corpus Callosum Sructural Integrity and Functional Motor Response 
Integrity 
Study Two provides evidence implicating the breakdown of fronto-striatal circuitry to 
aberrant electrophysiological premotor activity, which may represent one of the first deficits 
in pre-HD. However, the contribution of other motor networks is an important consideration, 
particularly given the possibility of network despecialisation/compensation in maintaining 
premotor functionality. Hence, in this study, we expanded our examination of functional 
connectivity of the corpus callosum. The corpus callosum is the major white matter 
commissure which connects hemispheric cortical grey matter regions. Only a minority of 
white matter fibres are innervated by fronto-striatal circuitry (Phillips et al., 2013), and thus 
the corpus callosum provides homotopic and heterotopic links to premotor, supplementary 
motor, and primary motor areas (among others) which are distinct connections from those of 
the striatum. Thus, we hypothesised that the corpus callosum itself provides a primary or 
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ancillary avenue to maintain functional motor connectivity, and that structural integrity also 
determines premotor activation (Figure 5.3).  
 
Figure 5.3 Schematic diagram illustrating thesis structure. 
 
In a combined sample we identified a number of correlations between electrophysiological 
premotor variables and the corpus callosum, including thickness in mid-posterior (motor) 
regions and greater early amplitude at Cz, and thinner mid-posterior regions with steeper 
slope at Fz. In mid-anterior regions (frontal cortex/premotor and supplementary motor areas) 
negative correlations were found with early amplitude at Cz, late amplitude at Fz, Cz and Pz, 
relative amplitude at Fz, and slope at Cz. These correlations did not survive type II (FDR) 
error corrections, but this could be due to the small sample size (N = 19) and heterogeneity in 
corpus callosum and in disease progression. However, our correlations follow known 
anatomical connections between motor and premotor regions (Alexander et al., 1986; Chao et 
al., 2009; Draganski et al., 2008). A large number of studies have identified atrophy to the 
corpus callosum as an anatomical marker of HD progression (e.g. Crawford et al., 2013; Di 
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Paola et al., 2012; Dumas et al., 2012; Klöppel et al., 2008; Phillips et al., 2013; Rosas et al., 
2006; Rosas et al., 2010;). Atrophy to this region could reflect early demyelination (Di Paola 
et al., 2012; Phillips et al., 2013), which progressively compromises connectivity of motor 
and premotor networks. While degeneration itself may give rise to ancillary processing, 
confounds such as heterogeneity in neuroanatomy, and difficulties in segmentation, may 
prevent identification of clear links between the corpus callosum and premotor activation. 
Thus Study Three, in part, supported the hypotheses that within a combined sample, premotor 
activation in HD would correlate with corpus callosum profile thickness in mid-sagittal (mid-
anterior) regions, which provide homotopic connections to premotor, supplementary, and 
primary motor regions. 
5.2 Limitations and Considerations 
5.2.1 Sample 
There are a number of limitations which should be acknowledged in regard to the sample. 
Firstly, the HD samples were relatively small (pre-HD = 20, symp-HD = 14 in Study One; 
ALL-HD = 19 in Study Two). With the exception of larger, well-funded, cross-institutional 
studies such as TRACK-HD and PREDICT-HD, studies in HD typically have < 30 
participants. Additionally, issues of disease stigmatisation and genetic discrimination at work 
and/or among family and friends (Penziner et al., 2007), variable rates of predictive testing 
(estimated less than 35% of at risk individual; Tassiker et al., 2009), fear of coverage 
rejection from health insurance companies (Oster et al., 2008), missing work, cognitive 
characteristics of the disease and care-giver burden impact on recruitment of persons with 
pre-HD. There is also an expected selection bias in that individuals earlier in the disease 
process are more likely to participate in research. This may inadvertently exclude individuals 
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with more significant motor impairment, including chorea from samples. This is generally 
advantageous, in that potential muscle interference during EEG and motor tasks is minimised, 
improving the quality of recordings and data. However, such interference from motor signs 
and feasibility of completing motor tasks with such individuals is therefore unknown, and 
should be evaluated in future studies on examining utility towards clinical trials. 
Of further concern is sample division. The cut-off between pre-HD and symp-HD is 
dependent upon the clinical observation of motor signs using the UHDRS (Huntington Study 
Group, 1996), the point of noticeable changes in the person. This represents an arbitrary and 
potentially uninformative cut-off, given that although the length of polyglutamine tract that is 
expanded in HD relates to age of onset, two individuals with the same polyglutamine length 
can vary by up to 36 years (Gusella & MacDonald, 2002), though this would be rare, with 
considerable heterogeneity present due to unknown genetic and epigenetic influences (Lee et 
al., 2012). Some studies attempt to better account for heterogeneity by splitting the pre-HD 
group into those near (< 5 years) and far (> 5 years) from onset. However, this requires a 
large sample, and these cutoffs too are determined by Langbehn’s (2004) prediction of onset 
model, which also relies upon CAG repeats. For these reasons a combined sample was 
elected for the structural analyses in Studies Two and Three.  
Additionally, in Study One, the symp-HD group was not matched to healthy controls, and 
were significantly older and more male predominant, the former of which could be suggested 
to undermine motor performance. Motor potentials/execution do not appear to differ by sex 
(Andreassi, 2006). With regard to executive functioning, due to the complex nature of the 
disease it is impossible to partial out specific features of the disease in order to ascertain 
contributions to motor dysfunction. Advanced age and declining executive function is a 
corollary of testing symptomatic HD individuals, and is typically countered for by covarying 
for age. The use of age as a covariate in studies that include both premanifest and 
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symptomatic groups is a common method to account, in part, for the effect of age (see 
Georgiou-Karistianis et al., 2012; Tabrizi et al., 2011). This increased the chance of type II 
error, but was unavoidable due to the lack of age-matched control group for the symptomatic 
group in Study One.  
 
5.2.2 EEG 
In our first study, we identified abnormal relative premotor activation in pre-HD. While we 
concluded this could reflect compensation, it is impossible to ascertain the cortical source and 
thus it may be entirely unrelated to premotor preparation. The decision to review only three 
electrode sites was taken to avoid an increased risk of type I error. While it is generally 
accepted practice in the MRP literature to review several sites where a whole brain 
topographic analysis of electrode sites is unnecessary (e.g. Ikeda et al., 1997), limiting sites 
consequently prohibits source localisation which might have provided further information on 
connectivity. Study One identified considerable variation in motor responses both between 
and within groups. This led to inclusion of peak-to-peak values to provide a more accurate 
reflection of elevation from baseline during the RP than peak amplitudes, which can be 
affected by a range of factors including motivation during the task (Andreassi, 2006; Ikeda et 
al., 1997).  
 
5.2.3 Neuroimaging and Connectivity 
Volumetric measurements condense morphological information and do not take into account 
subtle shape deflation. In neuroimaging studies in HD, cross-sectional volume measurements 
reveal substantial heterogeneity. The extent of this issue depends largely on the region, with 
greater variability noted in the ventricles rather than the caudate (Hobbs et al., 2010), despite 
controlling for age, sex, head size, and CAG length. Clear segmentation of regions for 
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volumetric analysis is dependent upon anatomical boundaries, with the caudate for example 
more easily segmented than the putamen (MacFarlane et al., 2015). Inter-individual 
differences make between group comparisons difficult, and can mask early, subtle volumetric 
loss.  
The structural bases of the electrophysiological changes we note are complex, and may relate 
to composite circuit factors as well as individual structural components as in the striatum and 
corpus callosum. Hence, inferences about functional connectivity made here are necessarily 
limited. Additionally, we restrict our measurements to specific structures of interest (the 
striatum and corpus callosum), which does not capture the entirety of a neural network. 
Indirect measurements of morphological changes may not be sensitive to pathology of HD, 
particularly in early stages, and could represent a composite of partial network changes as 
well as indirect effects, such as CSF and that of damaged tissue on the brain both globally 
and specifically. Further studies could address these issues by utilising measures such as DTI 
and EEG connectivity analyses to identify more vulnerable circuits as well as compensation 
mechanisms as atrophy progresses. 
 
5.3 Conclusions 
5.3.1 Implications for Future Studies  
There is a global effort to identify biomarkers in HD. While a number of studies have 
identified presymptomatic motor impairment, few have been reliably linked to structure, and 
many are single tasks, limiting their sensitivity and contribution to understanding motor 
localisation and neuropathology of the disease. Few studies have been replicated, failing to 
provide a consistent and established clinical biomarker of disease progression.  This work 
suggests that neural dysfunction during early stages can in fact present as over-activation. We 
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have expanded these findings to identify significant relationship between extent (amplitude), 
timing (latency), and consistency (relative-activation/slope) of premotor activity with 
integrity of the striatum, suggesting compromised fronto-striatal circuitry.  A better 
understanding about structural-functional integrity of specific neural circuitry impaired 
during the disease will inform function and pathophysiology of HD, such as in possible 
network despecialisation/compensation through progressive atrophy. 
It is worth noting the significant value of identifying such features of the disease. Although 
there is currently no treatments available, development and evaluation of future treatments 
will be significantly aided by a more comprehensive understanding of when and how the 
deficits in neural connectivity begin. Specifically, early targets such as the striatum may 
represent key areas for neuroprotective mechanisms, whereas comparatively well-preserved 
regions could provide better evaluation of longer term pharmacological interventions.  
A key goal in understanding the neuropathology of HD is to establish clear links between 
structural correlates of the disease and resulting impacts on functional connectivity. For a 
number of years research has focused on identifying neuropathology with the aim of 
developing structural biomarkers of the disease. While structural changes (using MRI) boast 
the greatest effect sizes, longitudinal changes in pathology are not well understood 
(Georgiou-Karistianis et al., 2013a). Although structural imaging is suitable for large scale, 
multi-site studies, the cost and accessibility of this technology limits its use across clinical 
settings, a fundamental recommendation for biomarkers (Biomarkers Definitions Working 
Group, 2001). Heterogeneity and natural variation in brain tissue should be considered as a 
difficulty in manual and automated segmentation of brain regions, particularly those with less 
pronounced anatomical boundaries such as the ventricles and putamen. For these reasons, 
structural studies are better suited to longitudinal designs, where individuals act as their own 
controls (Hobbs et al., 2010).  
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Structural studies provide considerable information regarding degeneration. However, we 
advocate for the use of correlational designs with simple motor tasks, to allow for inferences 
to be made regarding disruption to circuitry and functional connectivity. Simple tasks such as 
finger tapping show promise in elucidating disease-related processes and show promise for 
assessing treatment efficacy, due to their enhanced clinical usability (administration and 
evaluation) and repeatability (across time). Amalgamating functional and structural 
biomarkers will increase sensitivity and specificity, decreasing risk of type I error, or false 
positive diagnosis of onset (Pepe, 2003; Zhou, McClish, & Obuchowski, 2009). 
Demonstrating reliable links between structure and function with clinical utility in estimating 
disease onset will provide a baseline for pharmaceutical and neuroprotective interventions. 
Secondly, we observed considerable variation within both the presymptomatic and 
symptomatic groups in motor performance which was not accounted for by controlling for 
age, ICV, CAG repeats, or gender. These factors, combined with cognitive reserve (Papoutsi 
et al., 2014), highlight the complex nature of degeneration and preservation of motor 
performance. Thus, future studies could benefit from utilising combined clinical samples in 
correlational designs, without differentiating gene-positive individuals by symptomatic status 
in a discrete cut-off.  
 
5.3.2 Future Directions 
The results presented in this thesis need to be confirmed in a larger population to provide 
support for premotor neural activation as a clinical marker of Huntington’s disease. We 
suggest a replication and modification of our current study design, with a cross-sectional 
correlational study examining the link between striatal morphology, thickness of the corpus 
callosum and premotor activation in a much larger sample. Extending this study across 
timepoints would enable investigation of the decline to the motor response itself, an 
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interesting prospect considering the sharp dichotomy between chronic underactivation of the 
symptomatic CNV compared to over-activation of the presymptomatic CNV. Providing 
multiple scans of neuroanatomical points of interest enables individuals to act as their own 
controls, countering the issues of heterogeneity we raised earlier in masking group 
differences. Finally, extending beyond our simple finger tapping to a battery of motor tasks 
would create insight into whether motor functionality is maintained across tasks, or fails 
incrementally dependant on specific task demands. Expanding the repertoire to known motor 
tasks in HD and Parkinson’s disease which have yet to be examined concurrently with 
structural integrity, such as postural sway, motor overflow, and mirror tracing, could provide 
a comprehensive clinical battery for use in symptomatic diagnosis. As the CNV has identified 
aberrant premotor activation in pre-HD, this, combined with other tasks, could identify subtle 
deficits prior to the onset of motor impairment measurable by the UHDRS, and aid in 
diagnosis. Ultimately, early diagnosis for individuals may to assist in life planning. 
From a neurocircuit basis, future studies should investigate exactly how (and for how long) 
motor circuitry maintains functionality in a context of progressive atrophy. Equally important 
is an understanding of which circuits begin to fail first, and differentiating between more 
vulnerable and more robust circuits. This is essential to our understanding of disease 
neuropathology, and could result in a key, individualised intervention target to assist in 
maintaining patient functionality for longer.
 
5.3.3 Overall Conclusion 
Overall, this research supports the hypotheses that early, disease-related morphological 
changes to the striatum and corpus callosum disrupt critical fronto-striatal and inter-
hemispheric grey and white matter motor tracts. These changes to structural integrity of 
motor circuitry may impede functional connectivity in early stages of the disease, and thus 
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result in abnormal electrophysiological premotor activation despite largely intact functional 
motor performance (reaction time). Progression of circuit derangement could be mediated by 
ancillary activation occurring in secondary (e.g. the supplementary motor area, DLPFC 
circuit) regions and subcortical structures, which preserve connectivity and 
electrophysiological motor function as M1 connectivity declines.  
In our first study, we demonstrate that presymptomatic Huntington’s individuals show 
reliable neural differences from healthy controls in a subtle motor task (pressing a button at 
regular intervals). Motor areas in these individuals become active earlier and for longer, 
suggesting attempted compensation in a context of early atrophy and/or an inability to 
regulate motor responses. We theorised that aberrant premotor activation during a simple 
sensorimotor integration task (CNV) reflects disruption of critical inter-hemispheric circuitry 
such as fronto-striatal networks and major white matter tracts including the corpus callosum. 
However, this raised further questions as to how, when and why major motor circuits fail. In 
our second study we demonstrated associations between structure and function in a combined 
sample, suggesting that timing (latency) and consistency (relative activation/slope) of 
premotor activation is dependent upon structural integrity in the caudate and putamen, with 
later activation associated with greater atrophy. 
In our third study, we extended our investigation to the major white matter inter-hemispheric 
commissure, the corpus callosum, which provides parallel and converging grey matter inter-
hemispheric tracts between M1 and supplementary motor regions. We proposed that atrophy 
to the corpus callosum in regions corresponding to homotopic and heterotopic motor 
connectivity would be associated with abnormal premotor activation. While raw correlations 
suggest compromised mid-posterior (motor) and mid-anterior (frontal cortex/premotor and 
supplementary motor) regions have consequences for extent (amplitude) and consistency 
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(relative amplitude/slope) of premotor activation, results did not survive FDR (type II error) 
corrections.  
As a whole, our results indicate: a) that pre-movement brain activity is determined by 
functional motor connectivity, and becomes aberrant as the disease progresses and the brain 
is less able to provide network compensation/despecialisation to maintain motor 
functionality; and b) that electrophysiological premotor activation is a useful clinical marker 
of Huntington’s disease. This project contributes to the development of important biomarkers 
by demonstrating structure-function associations between a sensitive, replicable motor task 
and known anatomical landmarks in HD. 
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Statement of the Candidate’s Contribution to the Research 
This thesis has been reported as three studies, described in three respective chapters: 
 Study 1: Abnormal electrophysiological motor responses in Huntington’s disease: Evidence of 
premanifest compensation – published in PloS one 
 Study 2: Striatal morphology correlates with electrophysiological motor processing in 
Huntington’s disease: An Image-HD study – accepted, Brain & Behaviour 
 Study 3: Corpus Callosum thickness and associations with electrophysiological premotor 
processing in Huntington’s disease – under review 
The candidate was the lead investigator of all research presented in the thesis, developed 
research hypotheses and investigative plans, coordinated each of the studies (1-3), cleaned the 
data, designed and performed statistical data analysis, interpreted the results, and independently 
drafted and revised all chapters of this thesis in the context of supervisor feedback. The 
candidate is the principal author on all studies submitted for peer review. 
The research undertaken in Study 1 in this thesis stemmed from a study at Monash 
University, Melbourne Australia led by Professors, Rodney Croft and Nellie Georgiou-
Karistianis. In this study, recruitment, neuropsychological testing, and EEG were performed at 
Monash University by Lan Nguyen, a former PhD student. The candidate liaised with this 
research team and Dr Deborah Apthorp for collaboration and data access to a subset of this 
data, reported herein as Study 1: Abnormal electrophysiological motor responses in Huntington’s disease: 
Evidence of premanifest compensation. 
EEG data from Study 1 was combined with data from unrelated separate study at 
Monash University that analysed MRI images from some participants involved in Study 1, led by 
Prof Nellie Georgiou-Karistianis and A/Prof Jeffrey Looi. The candidate liaised with this 
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research team for collaboration and data access to a subset of the data analysed by Dr Fiona 
Wilkes, ANU Medical School, reported herein as Study 2: Striatal morphology correlates with 
electrophysiological motor processing in Huntington’s disease: An Image-HD study. Manual segmentation 
(measurement of shape and volume) of the caudate nucleus and putamen in the subset of data 
correlated with EEG data from Study 1 were performed by Dr Fiona Wilkes.  
Based on research plans hypothesised and designed by the candidate, the candidate 
liaised with and coordinated the advanced morphologic analysis of segmented MRI performed 
by Dr David Jakabek, Wollongong University, that generated additional results for study 2. 
Similarly, for study 3 the candidate planned and coordinated the corpus callosum mid-
sagittal thickness correlational analysis with EEG data from Study 1, performed by Dr Chris 
Adamson, Monash University in conjunction with Dr Deborah Apthorp, A/Prof Mark 
Walterfang and A/Prof Jeffrey Looi. [Corpus Callosum thickness and associations with electrophysiological 
premotor processing in Huntington’s disease].  
Co-authors were included from the respective parent research studies and collaborative 
centres on the basis of their significant intellectual, scientific work and material contribution to 
Studies 1-3.  
Study Publication Title Authors 
1 Abnormal electrophysiological motor 
responses in Huntington’s disease: 
Evidence of premanifest 
compensation 
 
Turner, L, M. 
Croft, R, J. 
Churchyard, A. 
Looi, J. C. L. 
Apthorp, D. 
Georgiou-Karistianis, N. 
 
2 Striatal morphology correlates with 
electrophysiological motor processing 
in Huntington’s disease: An Image-
HD study  
Turner, L. M. 
Jakabek, D. 
Wilkes, F. A. 
Croft, R. J. 
Churchyard, A. 
Walterfang, M. 
Velakoulis, D. 
Looi, J. C. L. 
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Apthorp, D. 
Georgiou-Karistianis, N. 
3 Corpus Callosum thickness and 
associations with electrophysiological 
premotor processing in Huntington’s 
disease 
Turner, L. M. 
Adamson, C. 
Croft, R. J. 
Churchyard, A. 
Walterfang, M. 
Velakoulis, D. 
Seal, M. 
Looi, J. C. L. 
Apthorp, D. 
Georgiou-Karistianis, N. 
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